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RIASSUNTO 
 
Introduzione: Il trattamento ottimale del flutter atriale (AFL) che si propaga lungo un circuito che 
comprende anche l’istmo cavo-tricuspidale (CTI) è l’ablazione transcatetere con radiofrequenza (RF) 
che si è dimostrata essere altamente efficace. Nonostante questa alta percentuale di successo 
l’ablazione può essere estremamente difficoltosa, a causa dell’anatomia altamente variabile del CTI. 
Abbiamo condotto uno studio per valutare come questa grande variabilità inter-individuale possa 
impattare sulla RF. L’obiettivo primario di questo studio era il successo della RF, definito come 
l’ottenimento del blocco bidirezionale del CTI in acuto. L’obiettivo secondario erano qualsiasi 
complicanza correlabile alla procedura e il tempo di procedura. 
Metodi: Sono stati arruolati 337 pazienti consecutivi in un periodo di 54 mesi. Un catetere decapolare 
5F era utilizzato per incannulare il seno coronarico (CS) e un secondo catetere multipolare 7F era 
posizionato anteriormente alla cresta terminale, nella parete libera dell’atrio destro, vicino all’anulus 
tricuspidale. L’anatomia del CTI era classificata in: CTI (A) semplice (superficie piatta), CTI (B) 
complessa (recesso tipo borsa di tabacco o superficie concava). Parametri vitali, come la misurazione 
della pressione arteriosa e della saturazione di ossigeno, venivano monitorizzati per tutta la procedura. 
I pazienti venivano sedati usando boli di midazolam e fentanyl. L’ablazione veniva terminata quando 
era evidente il blocco bidirezionale, usando un catetere 8 mm-tip con il limite di potenza di 70 W e 
un target di temperatura di 60°C. La lunghezza del CTI era misurata come la distanza lineare più corta 
tra il punto più basso dell’anulus tricuspidale e la vena cava inferiore, nella proiezione fluoroscopica 
antero-posteriore. Le visite ambulatoriali durante il follow-up erano programmate a 3, 6 e 12 mesi ed 
includevano un elettrocardiogramma 12- derivazioni ed un ECG di Holter. 
Contemporaneamente abbiamo studiato presso l’Unità di Patologia Cardiovascolare dell’Università 
di Padova, 104 cuori fissati in formalina di pazienti sottoposti ad autopsia di routine. Ogni cuore è 
stato esaminato da due esperti patologi cardiovascolari.   Sono stati valutati: 1.  la lunghezza 
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dell’istmo; 2. la presenza di recessi; 3. il numero di recessi; 4. la posizione dei recessi. E’ stata 
quindi eseguita l’analisi istologica. 
 
Risultati: 
 
Ablazione: L’età media della nostra popolazione era 62.8 ± 10.6 years (max 84; min 28), i maschi 
erano 236 (70%). Recessi sono stati trovati in 37 pazienti (10.9%) e il dato non era correlabile all’età, 
al sesso, alle dimensioni dell’atrio sx, alla frazione di eiezione (p = NS). La lunghezza media totale 
del CTI era 23.3 ± 3.9 mm (max 35; min 10). Il CTI era più corto nei soggetti con anatomia tipo A 
quando paragonati a quelli con anatomia tipo B (22.9 ± 3.2 vs 25.6±6; p = 0.01). L’end-point primario 
di efficacia, dimostrato dal blocco bidirezionale, è stato raggiunto nel 99.4% (335/337). L’insuccesso 
in acuto dell’ablazione (n = 2 pazienti) era associato ad una anatomia CTI di tipo B. 
Riguardo gli obiettivi secondari, è avvenuta una complicanza in 1 paziente (0.29%) con un’anatomia 
del CTI di tipo B: un “pop” immediatamente seguito da tamponamento cardiaco ha richiesto una 
pericardiocentesi urgente. Il tempo medio totale della procedura di RF è stato 51.6 ± 14.4 minuti, 
nessuna differenza trovata tra i 2 gruppi (p= NS), ma il blocco bidirezionale del CTI ha richiesto un 
tempo di applicazione di RF significativamente più lungo nell’anatomia del CTI di tipo B quando 
paragonata al tipo A (8.3 min vs 10.7 min, p = 0.025), a dimostrazione che in caso di anatomia 
complessa, l’ablazione risulta essere più difficoltosa. Durante il periodo di follow-up medio di 36.7 
± 17.2 mesi, il 99.7% (334/335) dei pazienti era libero da recidive di AFL. Nel paziente sintomatico 
con recidiva di AFL documentata all’ECG di Holter 24 ore e all’ECG 12- derivazioni, è stata 
dimostrata una ripresa di conduzione lungo la linea di ablazione.  E’ stata ripetuta l’ablazione e il 
paziente non ha più avuto altre recidive. 
Anatomia: L'età media degli individui era 67 ± 17 anni, con una prevalenza maschile (65%). Il peso 
medio del cuore era 457 ± 102 g. La lunghezza dell'istmo centrale era di 24 ± 4.1 mm (range 15 - 38 
mm) senza differenze tra i gruppi (24.1 vs 23.6, p = NS), rispettivamente. L'istmo centrale nei 
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pazienti affetti da flutter atriale era significativamente più lungo rispetto agli altri campioni (p 
<0.01). In 10 dei nostri casi (9.6%), era presente un recesso. Come nella serie clinica di pazienti 
sottoposti ad ablazione, la presenza di recessi non era correlata all'invecchiamento e al sesso. Il 
recesso era singolo nella maggior parte dei casi (60%) e la sede più frequente era l'istmo centrale 
(60%). Nei 4 cuori con diagnosi pregressa di flutter atriale, nessun recesso è stato trovato. Il numero 
più alto di recessi trovati in un campione era 3. Le regioni con la parete muscolare più sottile sono 
risultati essere l'anteriore, la parasettale mediale e la medio-centrale. 
Conclusioni: La nostra ricerca con studio elettrofisiologico ed anatomico ha fornito informazioni 
rilevanti per la pratica clinica. L'ablazione transcatetere dell'AFL tipico che coinvolge il CTI è stata 
confermata essere una procedura di ablazione sicura, efficace e consolidata. L'anatomia del CTI 
impatta sui parametri di ablazione, come l'applicazione di energia di RF. Inoltre, la procedura difficile 
è stata associata anche alla lunghezza maggiore dell'istmo. I recessi possono complicare l’ablazione, 
e sapere dove potrebbero essere presenti è utile per evitarle. Pertanto, nella nostra opinione, il tasso 
di successo e le complicazioni di ablazione possono essere ottimizzate da una profonda conoscenza 
dell'anatomia e dell'esperienza del centro. 
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SUMMARY 
 
Background: Radiofrequency (RF) catheter ablation targeting the isthmus between the tricuspid 
annulus and the inferior vena cava (IVC) is the established treatment for typical atrial flutter (AFL) 
due to its high efficacy. Despite this high success rate, ablation of the cavo-tricuspid isthmus (CTI) 
can be extremely difficult, due to its highly variable anatomy. The aim of this study is to analyze how 
and why the great inter-individual variability can influence ablation procedure. Primary endpoint was 
to evaluate the impact of the underlying CTI anatomy on acute and long-term success rate. Secondary 
endpoint was to determine any ablation related complication and procedure time. 
Methods: Over a period of 54 months, 337 consecutive patients underwent CTI ablation. One 5F 
decapolar catheter was placed within the coronary sinus (CS) and another 7F multipolar catheter was 
placed anterior to the crista terminalis at the right free wall close to the tricuspid annulus. CTI anatomy 
was classified into: (A) simple (flat) CTI, (B) complex (pouch-like recess or concave shape) CTI. 
Vital parameters, such as arterial blood pressure and oxygen saturation were monitored throughout 
the entire procedure. All procedures were performed under conscious sedation using boluses of 
midazolam and fentanyl. Termination ablation was decided when bidirectional block was 
demonstrated. Ablation was performed using 8 mm-tip catheter with a power limit of 70 W and a 
target temperature of 60°C. The CTI length was measured as the shortest linear distance between the 
lower hinge point of the tricuspid annulus and the IVC in the frontal fluoroscopic projection. 
Outpatient follow-up included 12-lead ECG, and Holter ECG monitoring, scheduled at months 3, 6, 
and 12. 
We also examined 104 formalin-fixed hearts from patients who underwent routine clinical autopsy 
performed at the Cardiovascular Pathology Unit, University of Padua. Every heart was examined by 
two independent expert cardiovascular pathologists. The following features were assessed: 1. the 
length of the central isthmus; 2. the presence of pouch-like recesses; 3. the number of the recesses; 
4. the position of the recesses. The histological analysis was performed. 
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Results: 
 
Ablation: Mean age of all patients was 62.8 ± 10.6 years (range 28 – 84), male was 236 (70%). Deep 
recesses were found in 37 patients (10.9%) and were not related to aging, gender, left atrial size, and 
left ventricle ejection fraction (p = NS). Total mean CTI length was 23.3 ± 3.9 mm (range 10 – 35 
mm). CTI length was shorter in type A anatomy as compared to type B (22.9 ± 3.2 vs 25.6 ± 6; p = 
0.01). The primary endpoint of efficacy, proved by the bidirectional block, was achieved in 99.4% 
(335/337). Acute ablation failure (n = 2 patients) was associated with a CTI type B anatomy. 
Regard to the secondary endpoints, complication occurred in 1 patient (0.29%) with the CTI type B 
anatomy: a “pop” immediately followed by cardiac tamponade required urgent pericardiocentesis. 
Total mean procedure time of was 51.6 ± 14.4 minutes, no difference between two groups (p= NS), 
but CTI bidirectional block was obtained with a significantly longer RF application time in CTI type 
B anatomy as compared to the type A (8.3 min vs 10.7 min, p = 0.025); that demonstrates ablation is 
more difficult in case of complex anatomy. During a mean follow-up period of 36.7 ± 17.2 months, 
99.7% (334/335) of the patients were free of AFL recurrences. AFL recurred in 1 symptomatic patient 
with CTI type B anatomy. The patient underwent second ablation procedure. Conduction across the 
ablation line was demonstrated. Successful ablation was performed. No new recurrences have 
occurred until this time. 
Anatomy: The mean age of the individuals was 67 ± 17 years, with a male prevalence (65%). The 
mean heart weight was 457 ± 102 g. The length of the central isthmus was 24 ± 4.1 mm (range 15 - 
38 mm) without differences between groups (24.1 vs 23.6, p = NS), respectively. The central isthmus 
in the patients affected by atrial flutter was significantly longer compared to the other cardiac 
specimens (p < 0.01). In 10 of our cases (9.6%), a sub-Eustachian recess was present. As in the 
clinical series of patients undergoing ablation, the presence of recesses was not related to aging and 
gender. The recess was single in the majority of cases (60%) and the most frequent location was the 
central isthmus (60%). In the 4 cases diagnoses with atrial flutter, no recess was found in the CTI. 
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The highest number of recesses found in one specimen was 3. The regions with the thinnest muscular 
wall resulted to be the anterior and middle paraseptal and middle central. 
Conclusions: Our investigation with both electrophysiological and anatomical study provides 
relevant information to clinical practice. Catheter ablation of typical AFL involving the CTI has been 
confirmed to be a safe, effective, and well-established ablation procedure. Nevertheless, the CTI 
anatomy impacts ablation parameters, such as RF energy application. Moreover, difficult procedure 
is also associated with longer length of isthmus. Recesses can complicate ablation, and knowing 
where they might be present is useful to avoid them. Therefore, success rate and ablation 
complications can be optimized by a deep knowledge of anatomy and centre experience. 
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ABBREVIATIONS 
AFL, atrial flutter 
AF, atrial fibrillation 
CTI, cavo-tricuspid isthmus 
ICV, inferior vena cava 
TV, tricuspid valve 
RF, radiofrequency ablation 
CS, coronary sinus 
AV, atrioventricular 
AADs, antiarrhythmic drugs 
RAO, right anterior oblique 
LAO, left anterior oblique 
NAO, new oral anticoagulant 
PPI, post pacing interval 
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Part I. 
 
ATRIAL FLUTTER 
Definition and History. 
 
INTRODUCTION 
 
Atrial flutter (AFL) is a frequent arrhythmia second only to atrial fibrillation (AF) in clinical practice. 
AFL has many clinical aspects that are similar AF but they are different in terms of mechanism and 
management. Some patients have both AFL and AF and both arrhythmias are associated with a risk 
of thrombus formation and thromboembolism. 
In 1906, Einthoven made an electrocardiographic recording of AFL [1]. Since 1913, Sir Thomas 
Lewis called attention to the typical saw-tooth pattern and the negative deflections of the atrial waves 
in leads II and III [2]. In 1921, Sir Lewis and his colleagues have also demonstrated that AFL was due 
to an intra-atrial circus movement around the vena cava [3]. During the next 50 years, there was much 
discussion about whether AFL was caused by a rapidly firing atrial focus or is the result of a large 
circus movement involving the atria. After mapping atrial activation with endocardial and esophageal 
recordings in 1970, Puech et al. identified two types of AFL, i.e. common and rare AFL. They 
concluded that the flutter cycle in the human heart involved activation of the whole right atrium and 
considered that the common type of AFL proceeded cranially along the inter-atrial septum and then 
caudally on the free wall of the right atrium [4]. Stimulation studies revealed that in postoperative 
AFL the arrhythmia was based on a reentry mechanism involving a large atrial area. They 
demonstrated the presence of an excitable gap that allowed the speeding up of the flutter rate during 
atrial pacing and termination of the arrhythmia by pacing [5-9]. In 1990, Olshansky et al., using a 
mapping and entrainment pacing technique, demonstrated that a critical area of slow conduction was 
present inferiorly and posteriorly in the right atrium [10]. Nowadays, it is so-called cavo-tricuspid 
isthmus (CTI). 
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Pathologic Studies. 
The CTI is a part of the right atrium located between the inferior vena cava (ICV) ostium and the 
hinge of the leaflets of the tricuspid valve (TV). The CTI reentrant circuit is a relatively new concept 
that was first introduced by Cosio et al. (1993) [11]. CTI is considered crucial in producing a 
conduction delay and, hence, favoring the perpetuation of a stable macro-reentrant circuit that has its 
basis in the anatomical structure of the right atrium. Therefore, the ideal target for radiofrequency 
ablation (RF) ablation is the critical zone of slowed conduction at the level of the isthmus of right 
atrium wall between the IVC and the TV [11- 14]. In particular, the route of the re- entrant circuit is 
bordered anteriorly by the tricuspid annulus and posteriorly by the IVC ostium, the crista terminalis 
and the Eustachian ridge [13]. 
Actually, a non uniform terminology exists between electrophysiologists and pathologists. The area 
between the Eustachian valve or ridge posteriorly, and the hinge of TV anteriorly, is described by an 
electrophysiologist as the posterior isthmus. According to the pathologists, with heart in the anatomic 
position, this component is inferior, and forms the base of a quadrilateral area [15]. The quadrilateral 
area is formed by Eustachian valve, Thebesian valve, TV, and a line connecting the IVC and TV [16] 
(Fig. 1A and 1B). Frequently, the area immediately anterior to the IVC ostium is composed mainly 
of fibrous and fatty tissue, with minimal muscular fibers coursing through it. The clinical implication 
is that this part of the isthmus needs the least RF energy. The middle part of the quadrilateral is made 
up of muscular trabeculations separated by delicate membranes. The trabeculations originates either 
from the wall of the coronary sinus (CS) or else are the continuations of the muscular bundles of the 
crista terminalis (pectinate muscles). The third anterior sector of the quadrilateral, adjacent to the 
hinge of the TV, is smooth, showing no evidence of trabeculations. Histological sections have 
confirmed that in this region the myocardium formes the full thickness of the atrial wall. The muscular 
trabeculae radiate from the terminal crest in almost parallel fashion without an appreciable cross-over 
or show abundant cross-over and interlacing trabeculae, particularly in the zone immediately inferior 
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to the CS ostium [17]. In this area, trabeculae to the right- and left-hand sides of the ostium are 
interconnected along the inferior rim. On this basis, one can easily speculate that non uniform 
anisotropic conduction occurs, and thus, a critical area of slow conduction has been identified in this 
region of the heart and plays an essential role in the AFL circuit [18,19]. 
Imaging Studies. 
 
By using 64-section multi-detector row computed tomography (Fig. 1C), Saremi et al. showed that 
the paraseptal isthmus was significantly shorter than the central isthmus and the central isthmus was 
shorter than the inferolateral isthmus ([20]. At mid-diastole, the central isthmus was straight in a small 
percentage of patients, concave and pouch like (>5mm) in an almost equal percentage. A sub- 
thebesian recess greater than 5-mm deep was identified in 45% of patients. A thick Eustachian ridge 
greater than 4 mm was seen as well. A pre-ablation magnetic resonance imaging study showed that 
the mean CTI length was 38.6 ± 7.8 mm. Lim et al. found recesses in 41% of patients. They also noted 
that CTI demonstrating an eccentric, septal recess required more RF energy to achieve isthmus block. 
The majority of patients (76%) had a concave CTI [21]. By using intracardiac three-dimensional 
echocardiography, Scaglione et al. demonstrated two different groups of CTI anatomy [22]. Group A 
patients showed a smooth isthmus with slight irregularities parallel to the tricuspid annulus, probably 
due to the pectinate muscles coming from the end of the crista terminalis in the low lateral right atrium. 
In this type of the isthmus, the Eustachian ridge was small. Group B patients presented a different 
isthmus anatomy due to a prominent Eustachian. The isthmus in these patients was a peak and valleys-
shaped structure. A prominent Eustachian ridge correlated with cases of resistant AFL ablation. A 
conduction gap crossing the isthmus was always present in that site. Chang et al., performed contact 
NavX mapping of the CTI, and found that the pouch-type CTI had a longer length than the flat-type 
CTI and a deeper depth than the concave type CTI. The pouch type CTI needed a longer ablation time 
and more RF pulses for ablation of the CTI [23]. 
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Figure 1A. Schematic view of the CTI regions. 
 
 
 
Figure 1B.  Position of catheters during ablation procedure. In the left anterior oblique projection (LAO), a 
multipolar mapping catheter (20 electrodes) is recognizable on the tricuspid ring, to record the electrical 
activity of the right atrium and the interatrial septal side wall, and a decapolar catheter in the coronary sinus. 
The other one is the ablation catheter (arrow) showing the three cavo-tricuspid isthmus regions: A: 
inferolateral isthmus. B: central isthmus. C: paraseptal isthmus. 
A B C
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Figure 1C. Left panel: Three levels (green arrows) of the CTI are shown: the inferolateral isthmus (ILI), the central 
isthmus (CI), and the paraseptal isthmus (PSI). The CI and the PSI are common targets for ablation of atrial flutter.  
Right panel: Graph shows results of comparison of length of three levels of the CTI at three cardiac phases (atrial 
contraction [0%], mid-ventricular systole [30%], and midiastole [70%]. The paraseptal isthmus was significantly 
shorter than the central isthmus and the central isthmus was significantly shorter than the inferolateral isthmus at all 
three cardiac phases. 
From: Saremi F, Pourzand L, Krishnan S, et al. Right atrial cavotricuspid isthmus: Anatomic characterization with  
multi-detector row CT. Radiology 2008;247:658–668. 
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Clinical Classifications, Epidemiology and Clinical Features. 
 
AFL can be divided into two types: 
 
Type I, or typical, (or common) is well described both anatomically and electrically. It is always 
being interrupted by rapid atrial pacing, with atrial rates from 240-350 bpm. 
Type II, or uncommon, (or reverse common), is now fully characterized. It is associated with atrial 
rates above 350 bpm. 
The typical AFL affects virtually the same spectrum of clinical situations of AF, but is rarer than AF 
in apparently non-cardiac subjects. It may be paroxysmal or permanent. Many patients with 
paroxysmal AFL have also paroxysmal AF. 
Paroxysmal atrial flutter can occur in patients without structural heart disease, while persistent AFL 
is constantly observed in cardiac patients.  It is usually associated with underlying heart disease,  such 
as rheumatic or ischemic heart disease or cardiomyopathy. It can occur as a result of atrial dilatation  
from  septal defects, pulmonary emboli, mitral or  tricuspid   valve stenosis or regurgitation, or chronic 
ventricular failure. Toxic and metabolic conditions that affect the heart, such as thyrotoxicosis, 
alcoholism, and pericarditis can cause AFL.  Occasionally, it can be congenital or follow surgery for 
congenital heart disease [24], or even occur in utero [25,26]. 
AFL is much less common than AF. Although the exact incidence is not known, it is estimated that 
its prevalence is less than 1 per thousand of the general population, but it is a common arrhythmia 
estimated to be present in approximately 10% of patients presenting with a supraventricular 
tachycardia [27]. The projected prevalence for 2050 was 0.15 million for AFL and 0.44 million for 
AF and AFL (Fig. 2). In few words, the current prevalence of AF and AFL is high and is projected to 
increase considerably by 2050. The prevalence increases with age. AFL is more common in men than 
in women. It is common during the first week after open heart surgery [28]. Permanent AFL with a 
rapid ventricular rate may lead to a tachycardia-mediated cardiomyopathy. Tolerance of the rapid 
 
19 
ventricular rate during AFL will be influenced by the presence of additional cardiac or pulmonary 
abnormalities. 
 
 
 
 
  AFL, atrial flutter; AF, atrial fibrillation 
From: Naccarelli GV, Varker H, Lin J, et al. Increasing Prevalence of Atrial Fibrillation and Flutter 
in the United States. Am J Cardiol 2009; 104:1534–1539. 
 
AFL tends to be unstable, reverting to sinus rhythm or degenerating into atrial fibrillation. Less 
commonly, the atria can continue to flutter for months or years. In AFL, the atria contract, which 
Figure 2. Left panel: Prevalence of (A) AFL only, and (B) AF and AFL stratified by gender
and age. Right panel: Projected prevalence of (A) AFL only, and (B) AF and AFL from
2005 to 2050.
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may, in part, account for fewer systemic emboli than in atrial fibrillation. In children, continued 
episodes    of    AFL    are    associated    with    an    increased    chance     of    sudden    death. AFL 
usually responds to carotid sinus massage with a decrease in ventricular rate in stepwise multiples,     
returning     in     a     reverse      manner      to     the      former      ventricular     rate   at the termination 
of carotid massage (Fig. 3A). Very rarely, sinus rhythm follows carotid sinus massage. Exercise by 
enhancing sympathetic or lessening parasympathetic tone, can reduce the atrioventricular (AV) 
conduction delay and  produce  a  doubling  of  the  ventricular  rate. Physical examination may reveal 
rapid flutter waves in the jugular venous pulse. If the relationship of flutter waves to conducted QRS 
complexes remains constant, the first heart sound will have a constant intensity. Occasionally, sounds 
caused by atrial contraction can be auscultated. 
The atrial rate during typical (type I) AFL is usually 250 to 350 beats/min. Ordinarily, the atrial rated 
is about 300 beats/min, and in untreated patients the ventricular rate is half the atrial rate, i.e. l50 
beats/min (Fig. 3A). A significantly slower ventricular rate (in the absence of drugs) suggests AV 
conduction. 
The hemodynamic tolerance of AFL depends on the baseline clinical situation and the AV conduction 
ratio. As the atrial rate of the flutter reaches around 300 beats/min, the ventricular rate is quite 
different if the conduction is 1:1 (very unlikely eventuality in the non-WPW patients), 2:1 (150 
beats/min), 3:1 (100 beats/min) or Luciani-Wenckebach. A second aspect to be considered for AFL 
is the possible abrupt increase in heart rate during adrenergic stimulation linked to the change of the 
AV conduction ratio. As a result, an AFL can be well tolerated at rest but not the same to the slightest 
effort. In children, in patients with the pre-excitation syndrome, occasionally in patients with 
hyperthyroidism, and in those with accelerated AV nodal conduction, AFL ventricular rate may be 
much faster. Lastly, the possible deleterious effect of some drugs (such as those of the class IC) 
currently being used for the potentially efficacy in the therapy and prevention of such arrhythmias 
should be considered. Such drugs tend to slow the atrial rate of flutter (to the range of 200 beats/min) 
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and may paradoxically favor an AV 1:1 conduction ratio. If, for example, in a patient's basic condition 
the AV node allows a conduction of 1:1 up to 220 beats/min, during AFL (having an atrial rate of 
about 300 beats/min), the AV conduction will be 2:1 and the ventricular rate of 150 beats/min. After 
taking a class 1C antiarrhythmic drugs (AADs), if the atrial rate drops to 220 beats/min, a ratio of 1:1 
will be possible and the ventricular rate may suddenly rise to 220 beats/min. Since, as we have said, 
AF and AFL are arrhythmias affecting similar patients, this problem should also be taken into account 
when we suggest these drugs for therapeutic or prophylactic purposes to patients with paroxysmal 
AF. Paroxysmal AFL, like other supraventricular paroxysmal tachycardia, does not involve severe 
hemodynamic consequences or particularly negative prognostic implications in the "healthy heart" 
patients, especially if the crises are rare and at a very low rate. In the cardiac patients, of course, the 
problem is different because a sudden increase in ventricular rate can break an unstable balance. 
Permanent AFL, similar to permanent atrial tachycardia, when it maintains a steadily high ventricular 
rate, may also result in the development of secondary cardiomyopathy in an otherwise previously 
normal heart or in the worsening of cardiac function in patients affected by heart diseases. The 
abolition of the arrhythmia, with transcatheter ablation, generally improves the function of the pump 
until the “cardiomyopathy” regresses. Uncommon AFL is rarer than the common one and often 
alternates with the first one. In general, what it said about the common flutter, it is also true for 
uncommon AFL. 
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Figure 3. Various manifestations of atrial flutter. A, Atrial flutter at a rate of 300 beats/min conducts 
to ventricle with 2:1 block. In the mid-portion of the tracing, carotid sinus massage converts the block 
to 4:1 and the ventricle rale slows to 75 beats/min. B, Carotid sinus. massage produces a transient 
period of AV block clearly revealing the flutter waves. C, Quinidine has slowed the atrial flutter rate 
to approximately 188 beats/min. The block is variable. D, Wide QRS complexes with an RSR’ 
configuration in V1 begin after a short cycle that follows a long cycle in the mid-portion of the ECG 
strip. This represents functional right bundle branch block. Arrows indicate flutter waves. E, The 
QRS, complexes are 0.12 sec in duration and have a regular interval at a rale of 200 beats/min. Atrial 
activity is also regular at a rate of 300 beats/min and independent from ventricular activity (arrows), 
Thus atrial flutter is present with a probable ventricular tachycardia, an example of complete AV 
dissociation. 
AV, atrioventricular 
From: E. Braunwald. Heart Disease. Textbook of Cardiovascular Medicine. 5th ed. 1997. Philadelphia, 
London,Toronto, Montreal, Sydney, Tokio. W. B. Saunders Company. 
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Electrocardiographic Recognition of Atrial Flutter. 
 
In typical AFL, flutter waves are atrial complexes of constant morphology, polarity and cycle length 
in a rate range from 240 to 340 beats/minute with classical aspect (sawtooth) (Fig. 3B and Fig. 4), 
often best visualized as negative waves in leads II, III, aVF and positive waves in V1 (Fig. 4 and Fig. 
5), and evidence of continuous electrical activity, that is to say lack of an isoelectric interval between 
flutter waves (Fig. 6 and Fig. 7). As a result of perpendicular spatial exploration of the activation line, 
the isoelectric line may be present in chest leads (Fig. 8). Transition of morphology across the anterior 
leads is consistent with a counterclockwise atrial circuit with lateral-to-medial activation of the CTI. 
 
 
 
 
Figure 4. Standard electrocardiogram in common AFL. Note sawtooth waves F. 
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Figure 5. Simultaneous atrial flutter and sinus rhythm. In this patient with a heart transplant, the 
recipient atrium exhibits atrial flutter, best seen in leads II, IlI and aVF while the donor atrium exhibits 
sinus rhythm (best seen in chest leads). 
From: E. Braunwald. Heart Disease. Textbook of Cardiovascular Medicine. 5th ed. 1997. Philadelphia, 
London,Toronto, Montreal, Sydney, Tokio. W. B. Saunders Company. 
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Figure 6. Electrocardiogram peripheral leads in common AFL. Note the classic sawtooth 
appearance in D2, D3, and aVF. The AV conduction ratio is 2:1. 
From: P. Delise. Le tachiaritmie sopraventricolari. Dall’elettrocardiogramma all’ablazione 
transcatetere. Ed. 1997. Casa Editrice Scientifica Internazionale. 
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Figure 7. Common AFL. In the peripheral leads, the classic sawtooth waves (without interposed 
isoelectric) linked to the flutter counterclockwise macro-circuit running through the right atrium. In 
this case there are periods of QRS aberrancy type left branch block. The branch block appears in the 
presence of short R-R cycles and disappears during long R-R cycles (linking phenomenon). 
From: P. Delise. Le tachiaritmie sopraventricolari. Dall’elettrocardiogramma all’ablazione 
transcatetere. Ed. 1997. Casa Editrice Scientifica Internazionale. 
 
 
 
 
 
Figure 8. As a result of perpendicular spatial exploration of the activation line, the isoelectric line 
may be present in chest leads. 
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In the ECG uncommon flutter waves generally have a faster rate of the typical flutter and are positive 
in leads II, III, aVF, broad, inverted flutter waves in V1, which accounts for 5-10% of all CTI-
dependent flutter. The AV conduction ratios are as in the typical flutter. The rate in uncommon AFL 
is 350 to 450 beats/min. 
 
 
 
 
Figure 9. Surface 12-lead ECGs during counterclockwise (left) and clockwise (right) typical atrial 
flutter. In clockwise atrial flutter, the flutter waves are positive because of a clockwise reentrant 
pathway. 
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If the AV conduction ratio remains constant, the ventricular rhythm will be regular; if the ratio of 
conducted beats varies (usually the result of a Luciani-Wenckebach AV block), the ventricular rhythm 
will be irregular. Alternation between 2:1 and 4:1 AV conduction often occurs and may be due to two 
levels of block-2:1 high in the AV node and 3:2 lower down. The irregular ventricular response is 
frequently due to Luciani-Wenckebach periodicity. Recurrent alternation of short and long ventricular 
intervals can be due to concealed conduction (Fig. 7). Various degrees of penetration into the AV 
junction by the flutter impulses also can influence AV conduction. The ratio of flutter waves to 
conducted ventricular complexes most often is an even number (e.g., 4:1, and so on). 
Generally, diagnosis is simple because the conduction ratio to the ventricles (usually 2:1, 3:1, 4:1, 
Luciani-Wenckebach, etc.) That makes it easily distinguishable. The waves F rate is classically 
around 300/min (range 230-260). Some difficulties can arise when there is an AV 1:1 conduction to 
the ventricles (e.g. in the presence of anomalous pathway like Kent, Fig 10). In this case the waves F 
may be completely or partially masked in the wave T of the previous beat and may be decisive for the 
diagnosis to be able to modify the AV conduction ratio. This condition is rarely, but not impossible. 
Impure flutter (flutter-fibrillation), occurring at a rate faster than pure flutter, shows variability in the 
contour and spacing of the flutter waves and in certain instances can represent dissimilar atrial 
rhythms, i.e., fibrillation in one atrium and a slower, more regular rhythm resembling AFL in the 
opposite atrium. Prolonged atrial conduction time has been found to be a predisposing factor for the 
development of AFL. 
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Figure 10. AFL in left posteroseptal accessory pathway. The conduction is 1:1 and the traces 
simulates a ventricular tachycardia. 
 
 
Management of Atrial Flutter. 
 
The goals for the management of AFL are similar to those for AF [29,30]. Based on the available 
evidence [31], the stroke risk in patients with AFL is not much different from that in AF [32]. 
Furthermore, many patients diagnosed with AFL develop AF [33–35]. Thus, anticoagulation should 
be used in patients with AFL similar to that in patients with AF. 
Rate control in AFL is achieved with the same medications as in AF, but is often more difficult to 
reach. Perpetuation of AFL requires that the tachycardia circuit be longer than the product of 
conduction velocity of the circulating impulse and the duration of the refractory period in the circuit 
(the so-called wave length). To terminate the arrhythmia, therefore, a drug should be given which 
does not slow conduction velocity but rather prolongs the refractory period within the tachycardia 
circuit, inhibiting continuation of the circulating wave front [36–38]. 
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When deciding on pharmacological therapy, side effects and the possible dangers of drug 
administration should be considered. Class III drugs can produce torsade de pointes arrhythmias [39]. 
This occurs in 1% to 4% of patients and is related to dose and presence of abnormalities in cardiac 
and kidney function. As it said, class I drugs may lower the flutter rate, resulting in 1:1 AV conduction 
and a much faster ventricular rate. Especially in the case of class I-C drugs, this may be accompanied 
by marked QRS widening and initiation of ventricular tachycardia. QRS widening on ventricular rate 
increase may vary individually. It is therefore advisable to perform an exercise test after treatment 
with a class I-C drug has been initiated. If QRS widening on ventricular rate increase occurs, the class 
I-C drug should be discontinued, and/or a drug prolonging the refractory period of the AV node should 
be administered. In summary, flecainide, propafenone, dofetilide, and intravenous ibutilide are useful 
for cardioversion of AFL, but they should be combined with a rate- controlling agent to avoid 1:1 
conduction of slowing flutter waves to the ventricles. (Fig. 11). For acute termination of AFL, 
intravenous ibutilide is more effective for conversion of AFL than AF, whereas vernakalant is less 
effective in converting typical AFL [40-43]. 
Verapamil or diltiazem to slow the ventricular response during AFL can be tried. Calcium antagonists 
can restore sinus rhythm in patients with AFL of recent onset but less commonly terminate permanent 
AFL. Adenosine produces transient AV block and can be used to reveal flutter waves if the diagnosis 
of the arrhythmias is in doubt. It generally will not terminate the AFL and  can provoke AF [44]. 
Esmolol, a beta-adrenergic blocker with a 9-min elimination half-life, can be used to slow the 
ventricular rate [45]. 
For prevention of recurrence, two aspects have to be considered. The arrhythmia is usually caused by 
one or more atrial premature beats that can be prevented by class I drugs (flecainide, procainamide, 
quinidine), class III drugs, and amiodarone. Maintenance of the arrhythmia can be prevented by 
prolonging the wave length of the circulating impulse by class III drugs [46]. 
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Figure 11. AFL IC (Flecainide). The conduction is 1:1 and the traces simulates a ventricular 
tachycardia. 
 
 
External electrical cardioversion has been used to terminate AFL since its introduction by Lown et al 
[47]. Synchronous direct-current cardioversion of AFL can be performed [48]. It is commonly the 
initial treatment of choice for AFL, since cardioversion promptly and effectively restores sinus 
rhythm, often requiring relatively lower energies (<50 joules) than for AF [49,50]. If the electrical 
shock results in AF, a second shock at a higher energy level is used to restore sinus rhythm or, 
depending on the clinical circumstances, the AF can be left untreated. The latter can revert to AFL or 
sinus rhythm. The method is safe and effective, terminating AFL in >90% of episodes. 
If the patient cannot be electrically cardioverted or if electrical cardioversion is contraindicated, for 
example, after large amounts of digitalis are administered, rapid atrial pacing (atrial overdrive pacing) 
through pacemaker leads or endocardial catheter or catheter in the esophagus [51] or the right atrium 
can terminate type I (but not type II) AFL effectively in most patients, producing sinus rhythm [52,53] 
or AF with a slowing of the ventricular rate and concomitant clinical improvement [54-56]. 
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Anticoagulation and transesophageal echocardiogram around cardioversion or overdrive pacing 
should be used similar to that in AF. 
As it said, ventricular rate control during permanent AFL is very difficult. Nevertheless, drugs that 
prolong the refractory period of the AV node, such as β-blocking agents, calcium antagonists, 
digitalis, and amiodarone. should be prescribed. Digitalis can be tried alone or with a calcium 
antagonist or beta blocker. The dose of digitalis necessary to slow the ventricular response varies and 
at times can result in toxic levels because it is often difficult to slow the ventricular rate during AFL. 
Frequently, AF develops after digitalis administration and can revert to normal sinus rhythm upon 
withdrawal of digitalis; occasionally, normal sinus rhythm may occur without intervening AF. 
Intravenous amiodarone has been shown to slow the ventricular rate as effectively as digoxin [57] and 
it is the most suggested in the current clinical practice. If the AFL persists, class IA or IC drugs can 
be tried to restore sinus rhythm and to prevent a recurrence of atrial flutter [58]. Amiodarone, also 
can help to achieve ventricular rate control. Because of the vagolytic action of quinidine, 
procainamide, and disopyramide, but primarily because of the ability of class I drugs to slow the 
flutter rate, AV conduction can be facilitated sufficiently to result in a 1:1 ventricular response to the 
AFL (Fig. 12). Side effects of these drugs, especially proarrhythimic responses, must be carefully 
considered. Sometimes treatment of the underlying disorder, such as thyrotoxicosis, is necessary to 
effect conversion to sinus rhythm. In certain instances, AFL can continue, and if the ventricular rate 
can be controlled with drugs, conversion to sinus rhythm may not be indicated. Class I and III drugs 
should be discontinued if flutter remains. It is important to reemphasize that class I or III drugs should 
not be used unless the ventricular rate during atrial flutter has been slowed with digitalis or a calcium 
antagonist or beta-blocking drug [59]. In any case, both prevention of recurrent AFL and the 
ventricular rate control are often difficult to achieve. 
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Figure 12. Atrial flutter with 1:1 conduction caused by flecainide. In the top panel, atrial flutter occurs 
with 2:1 conduction. In the middle panel, 2:1 conduction alternates with 3:2 conduction. In the bottom 
panel, flecainide has been started and the atrial flutter rate slows, resulting in 1:1 conduction. 
From: E. Braunwald. Heart Disease. Textbook of Cardiovascular Medicine. 5th ed. 1997. Philadelphia, 
London,Toronto, Montreal, Sydney, Tokio. W. B. Saunders Company. 
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ELECTROPHYSIOLOGY OF ATRIAL FLUTTER 
 
Atrial arrhythmias can be broadly classified as focal, small circuit, or macroreentry. Macroreentry is 
likely responsible for most form of usual AFL [60]. A definitive contribution to understand the 
mechanisms of AFL came from clinical electrophysiology. Over the years, it has been first made clear 
that the common AFL circuit is always located in the right atrium, while the left atrium is passively 
activated. An entrainment (see below) performed from the right atrium with a post pacing interval–
flutter cycle length of 20 msec demonstrates to be within the circuit. 
Cavotricuspid isthmus-dependent flutter is the archetypal atrial macro-re-entrant arrhythmia, the 
anatomical circuit of which has now been well described with both conventional and newer mapping 
modalities [11,12,61,62]. The most common forms of atrial macro-reentry are variants of classical 
common and uncommon CTI-dependent flutter (Fig. 13). These include both counterclockwise (type 
I, common) and clockwise (type II, reverse common) variants, with the circuit originally described as 
a broad active wavefront rotating around the tricuspid annulus. However, it is now recognized that 
many variants exist [63,64], such as lower loop reentry and forms in which the active wavefront 
crosses immediately anterior or posterior to the IVC. Rarely, intra-isthmus reentry can occur. 
The macro-reentry of typical AFL in the right atrium, with the left atrium passively activated, 
therefore, consists of a counterclockwise rotation around the tricuspid ring with a caudocranial 
direction in the inter-atrial septum and with a craniocaudal direction in the right atrial free wall [60, 
65-73]. Particularly, its descending branch occupies the lateral wall of the right atrium, in front of the 
terminal crest, and the ascendant one occupies the inter-atrial septum. The circuit is stereotyped 
because it is forced by a series of anatomic barriers: the terminal crest exactly, the IVC ostium, the 
CS ostium (in the posterior third of Koch's triangle, next to the slow pathway), the Eustachian ridge 
(combining both IVC and CS ostium) and obviously the tricuspid ring [74]. These anatomic barriers 
delimit certain restricted areas of myocardial tissue (isthmuses) that represent obligatory crossing 
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points of the circuit, critical areas to maintaining of reentry. Infact, a zone of slow conduction is 
typically bounded from the posterolateral to posteromedial inferior right atrium with a central area of 
block that can include an anatomical (IVC and tricuspid ring) and functional component [10, 75,76]. 
 
 
 
 
Figure 13. Schematic drawing showing mechanisms of AFL. A: Isthmus-dependent reverse type II 
(clockwise) AFL. B: Isthmus-dependent type I (counterclockwise) AFL. 
From: Search Engine. ClinicalGate, 2015. https://clinicalgate.com 
 
 
Tai et al demonstrated that incremental pacing from the low lateral right atrium and CS during sinus 
rhythm produced the rate-dependent conduction delays in the low right atrial isthmus, especially the 
middle and septal isthmus contiguous to the posterior triangle of Koch [37]. Furthermore, the gradual 
conduction delay with unidirectional block in the isthmus was relevant to the development of 
counterclockwise and clockwise atrial flutter. Patients with clinical AFL had much slower conduction 
in the low right atrial isthmus and shorter effective refractory periods in the right atrium than those 
without clinical AFL. This suggests slow conduction in the low right atrial isthmus plays an important 
role in the development of AFL. Feld et al. also found that conduction velocity was slower in the CTI 
than in the right atrial free wall and interatrial septum [77]. Furthermore, conduction velocity was 
slower in the CTI in the patients with type 1 atrial flutter than in those without a history of atrial 
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flutter. Olgin et al. demonstrated that pacing from the smooth right atrium induced counterclockwise 
atrial flutter, whereas pacing from the trabeculated right atrium induced clockwise atrial flutter [78]. 
Hence, the site of uni-directional block during initiation of either form of flutter is in the low right 
atrial isthmus. 
Placing an ablation lesion (surgical or trans-catheter) across the zone of slow conduction abolishes 
the AFL and prevents recurrence. This can be accomplished near the entrance of the slow zone in the 
low posterolateral right atrium, at the midpoint of the slow zone in the posterior right atrium, or near 
the exit at the posteromedial right atrium. The most easily attackable isthmuses for their relatively 
small extension are two. The first one is interposed between the tricuspid ring and the IVC ostium. 
The second one is located between the tricuspid ring and the ostium of the CS. In some instances, the 
second isthmus also includes a portion of atrial tissue beneath the CS ostium and extends for a few 
millimeters to the Eustachian ridge by involving a myocardial strip interposed between the Eustachian 
ridge and the same ostium (Fig. 14). 
It is possible that several different reentrant circuits exist in patients with atrial flutter. However, this  
area of slow conduction is rather constant and represents the site of successful ablation of AFL. It is 
also important in the conversion of AFL to AF [67]. Double potentials can be recorded from this area, 
with each one reflecting activation on either side of the block [71]. Ventricular activation can 
modulate the AFL rate, probably through mechanotechnical coupling, and atrial volume changes 
[73,79]. Ablation results are consistent with a macro-reentry circuit [11,76,80-85]. 
The diagnosis of AFL is very easy using only the standard electrocardiogram. The endocavitary 
electrophysiological study provides many interesting data but rarely is indicated for diagnostic 
purposes. 
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Figure 14. Re-entry circuit in common atrial flutter. Note the two mandatory isthmuses (through 
which pulses must pass) between ICV and TV and that between CS and TV. The flutter circuit is 
located entirely in the right atrium with a sense of counterclockwise rotation. 
SCV, Superior Vena Cava; ICV, Inferior Vena Cava; CS, Coronary Sinus; FO, Foramen Ovale; IS, 
Interatrial Septum; AVN, Atrium-Ventricular Node; LA, Left Atrium; TV, Tricuspid Valve. 
From: P. Delise. Le tachiaritmie sopraventricolari. Dall’elettrocardiogramma all’ablazione 
transcatetere. Ed. 1997. Casa Editrice Scientifica Internazionale. 
 
 Uncommon Atrial Flutter. 
 
The uncommon AFL is defined as a rapid and organized arrhythmia, such as the typical flutter, but it 
has a different morphology of atrial waves that are positive in the inferior derivatives. It is believed 
that in most cases it is linked to an atrial macro-reentry, but the focal origin cannot be excluded in 
particular cases. Some subjects alternate typical and uncommon AFL episodes. In some of these cases 
it has been shown that uncommon AFL uses the same circuit of common AFL but in the opposite 
direction, that is, clockwise rather than counterclockwise. 
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             RADIOFREQUENCY ABLATION OF ATRIAL FLUTTER 
Ablation. 
Catheter ablation has come a long way since its introduction in the early 1980s [86]. Catheter ablation 
of arrhythmias is growing at a rapid pace, with a 30-fold increase in the number of procedures from 
the late 1980s to 1990 [87]; it is now considered first-line therapy in many arrhythmias [88]. AFL has 
been one of the atrial tachyarrhythmias in which RF ablation has been early and largely used. 
Understanding the electrophysiology of the reentrant pathway for common and uncommon AFL, and 
the anatomy of CTI is essential to developing an ablation ideal approach. 
As we known, the common AFL is supported by a macro-reentry located in the right atrium, around 
the tricuspid ring and with a sense of counterclockwise rotation. The uncommon AFL has a clockwise 
rotation. 
The circuit comprises two tissue isthmuses through which the pulse passes obligatorily: one located 
between the IVC and the tricuspid ring and the other one located between the tricuspid ring and the 
CS ostium. 
A variable number of catheters inside the atrium can be used for reconstructing the circuit. (Fig. 15 
and 16). Classical succession of atrial activation can be documented with these methods. 
Two main techniques can lead to the location of the two critical isthmus where radiofrequency can 
be applied and created the lesion: the anatomical or electrophysiological technique. 
The anatomical technique consists in positioning the ablation catheter on one or both of the isthmuses 
by radiological guide. A catheter in the CS should be first introduced to locate the isthmus between 
the CS and tricuspid valve, so that it can become the radiological reference of its ostium. It is 
sometime useful to have a catheter in the Hisian area to identify the anterior portion of the tricuspid 
valve. It is convenient to check the position of the ablation catheter using all of the three standard 
fluoroscopic projections. 
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In fact, it is difficult to locate with certainty the position of the tip of a given catheter using a single 
fluoroscopic projection. The use of two orthogonal projections, like the oblique ones, permits a more 
accurate location of the exploring electrode within the three dimensions of the heart. The right anterior 
oblique (RAO) projection defines what is anterior, posterior, superior, and inferior in cardiac planes 
and permits to open and see “in front” the Koch's triangle, so could be used as reference in order that 
ablation catheter should be placed in front of the CS ostium. The frontal view could be used to 
introduce and position catheters in the high-lateral right atrium and follow the catheter during the 
ablation, in particular when moving from the middle isthmus until to fall in IVC. The left anterior 
oblique (LAO) projection is generally used to catheterize the CS independently of the venous 
approach used. This projection defines superior, inferior, anterior, and posterior locations for the right 
grooves and permits to confirm the correct position of all catheters and to understand if the ablation 
catheter is pointing against the septum or if it has accidentally moved away from it. 
The guided technique by the electrophysiological criteria is based on two principles: 1) the 
identification of delayed pulse areas localized within one or both isthmuses; 2) locating a point where 
“concealed entrainment” can be performed. The detection of delayed areas can be performed both in 
sinus rhythm and during flutter. In both cases, slow pulse progression can be evidenced by recording 
a fragmented, low voltage electric activity, with increased duration up to 100 msec or more. During 
AFL, the earliest activation point, compared to the beginning of wave F, is found at the level of the 
isthmus between the IVC and TV in postero-lateral side (usually the activation is about 100-150 msec 
before the wave F), then it is in the postero-medial area (proceeding the wave F of -60/70 msec) and 
finally follows between the CS and the TV. 
 
40 
 
 
 
Figure 15. Endocardial activation during counterclockwise (upper panel) and clockwise (lower 
panel) typical atrial flutter in the same patient. Catheter position and wavefront activation during the 
arrhytmia are illustrated in a left anterior oblique fluoroscopic view (right side). The ablation catheter 
(Abl) is positioned at the cavotricuspid isthmus (CTI), and the Halo catheter is positioned around the 
tricuspid annulus. The terminal segment of the Halo catheter explores the inferior isthmus, whereas 
the mid- and proximal electrodes explore the right atrial lateral wall anterior to the terminal crest. 
ABL, ablation site; CS, coronary sinus; CSdist, distal coronary sinus pole; CSprox, proximal coronary 
sinus pole; TAdist, distal tricuspid annulus pole; TAprox, proximal tricuspid annulus. 
From: Search Engine. ClinicalGate, 2015. https://clinicalgate.com 
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Figure 16. Panel A. Typical atrial flutter, with negative flutter waves in leads II and III. The insert (upper 
right) is a schematic of the right and left atria. A catheter has been inserted through the inferior vana cava 
and loops around the right atrium. Electrodes 1 to 10 are marked and correspond to electrogram 
recordings TA1 to TA10. Note that the atrial activation sequence proceeds in a counterclockwise direction 
from TA1 to TA10, cephalad up the septum and caudally down the right atrial free wall. HBE = His 
bundle electrogram; RV = right ventricular electrogram; I, II, III, and V1= scalar recordings. Panel B. 
Uncommon atrial flutter in the same patient, with flutter waves positive in leads II and III. Recordings as 
in panel A. Note that the activation sequence travels in a clockwise direction in this example from the 
same patient. 
From: E. Braunwald. Heart Disease. Textbook of Cardiovascular Medicine. 5th ed. 1997. Philadelphia, 
London,Toronto, Montreal, Sydney, Tokio. W. B. Saunders Company. 
A 
B 
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The energy has first to be delivered to the tricuspidal side (where the atrial deflection has a lower 
voltage than the ventricular one) by proceeding then towards the atrial side (where atrial deflection 
has a higher voltage than the ventricular one). 
To find the isthmus between the IVC and TV, the ablation catheter is introduced into the right 
ventricle. Using LAO (with which the two atrium-ventricular rings in front are seen), the same 
catheter slowly withdraws into the atrium until its distal pole is placed on the lower edge of the TV. 
The recording of a good voltage atrial deflection helps to know if you are in the correct position. The 
energy is delivered here, then along the entire isthmus by retracting the catheter until to the atrium to 
create a real surgical cut between the IVC and the TV (Fig. 17 and 18). 
The "concealed entrainment" described is a phenomenon that occurs when it is stimulated at a critical 
point of the circuit during spontaneous arrhythmia by capturing the same at a higher frequency. 
"Concealed entrainment" can be obtained in all three of the above positions. During stimulation, the 
flutter wave morphology is the same (in the 12 leads) to the spontaneous one, the ST-F interval is as 
longer as the catheter stimulates at the beginning of a delayed zone and finally when the pacing is 
stopped, the flutter continues with an interval between the last pacing flutter wave and spontaneous 
flutter wave equal to the original flutter cycle. In some subjects, with episodes of paroxysmal AFL, 
the same arrhythmia is not inducible during the electrophysiological study for which there are no 
alternatives to ablation during sinus rhythm. 
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Figure 17. Panel A. Schematic reproduction of common flutter circuit ablation technique putting 
catheter on the isthmus between CS ostium and TV. In the figure are recognizable superior and inferior 
vena cava ostium (SVC and IVC, respectively), coronary sinus ostium (CS), tricuspid valve (TV), 
node-Hisian axis (AVN-His-RB) and aorta (Ao). Furthermore, SN, Sinus Node.  Flutter circuit is 
drawn with the two obliged isthmus between IVC and TV and between CS and TV. Panel B. Schematic 
reproduction of the common atrial flutter circuit ablation technique putting the catheter on the isthmus 
between IVC and TV. RB, Right Branch; LB, Left Branch; RV, Right Ventricle; IVS, Inter-Ventricular 
Septum. 
 
From: P. Delise. Le tachiaritmie sopraventricolari. Dall’elettrocardiogramma all’ablazione 
transcatetere. Ed. 1997. Casa Editrice Scientifica Internazionale. 
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Figure 18. Positioning of catheters during the ablation of the cavo-tricuspid isthmus atrial flutter. In 
the right anterior oblique projection (RAO), a catheter is recognizable on the bundle of His (to the 
right looking at the figure), one in the coronary sinus that moves posteriorly, and a third catheter in 
front of the coronary sinus ostium which directs anteriorly. The latter is the ablation catheter (arrow). 
In the left anterior oblique projection (LAO), the three catheters are reviewed. The ablation catheter 
comes forward and rest on the tricuspid ring. 
From: P. Delise. Le tachiaritmie sopraventricolari. Dall’elettrocardiogramma all’ablazione 
transcatetere. Ed. 1997. Casa Editrice Scientifica Internazionale. 
 
 
Some Authors prefer ablation during sinus rhythm even in subjects with inducible AFL, for greater 
catheter stability during radiofrequency delivering. The electrophysiological endpoint of ablation 
during sinus rhythm is to create a bi-directional conduction block between the postero-lateral portion 
of the atrium that is around the TV and the area in front of the CS ostium (Fig. 19). This block, created 
by the linear lesion of one of the two isthmuses described above, is the precondition for preventing, 
countering the macro-reentry of arrhythmia. The demonstration of this block is as follows. 
RAO LAO 
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Figure 19. There is a catheter in the Hisian area (His Distal, Inter-medium and Proximal) and one in 
the postero-lateral tricuspid (LRA) site. Stimulation occurs from the coronary sinus during 
radiofrequency ablation. Two complexes are showed. Note that in the second complex the Stim-A 
interval in His-P remains constant. On the contrary in LRA the Stim-A interval changes from 85 to 
139 msec. This delay appeared during radiofrequency ablation and is linked to the creation of cava- 
tricuspid isthmus block. 
From: P. Delise. Le tachiaritmie sopraventricolari. Dall’elettrocardiogramma all’ablazione 
transcatetere. Ed. 1997. Casa Editrice Scientifica Internazionale. 
 
 
Under basal conditions a pacing from the area around the CS ostium is performed and several points 
of the tricuspid circumference are recorded. The points have to be at least two or three: the Hisian 
area, the postero-lateral region of the tricuspid valve, and the lateral right atrium. By stimulating the 
ostium of the CS, the pulse spreads around the tricuspid in a counterclockwise direction along the 
interatrial septum and in a clockwise direction along the posterior edge of the tricuspid. It follows 
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that the activation of the Hisian area and the postero-lateral tricuspid wall occurs almost 
simultaneously while the high right lateral wall is triggered later. After the ablation of one of the two 
isthmuses, the pulse delivered from the CS is forced to activate the peri-tricuspidal atrial myocardium 
only in counterclockwise direction. It follows that the Hisian area is activated firstly, then the high 
right atrial wall and, later, the postero-lateral wall. Similarly under basal condition, if stimulated by 
the postero-lateral wall, the pulse spreads around the tricuspid both in the clockwise direction (along 
the side wall) and counterclockwise (along the posterior and medial wall). Therefore, the high right 
lateral wall and the CS ostium will activate almost simultaneously while the peri-hisian area will be 
activated later. After the ablation of one of the two atrial isthmuses, the pulse delivered by the postero-
lateral wall is forced to activate peri-tricuspid myocardium only in the clockwise direction. It follows 
that the first activated zone is the high lateral right atrium, then the Hisian area and, only later, the CS 
ostium (Fig. 20). 
In patients in whom this electrophysiological endpoint is reached, of course, the confirmation of the 
no-reinducibility of the flutter should be searched when it is inducible under basal conditions. The 
ablation endpoint during induced or persistent AFL is the flutter interruption and restoration of sinus 
rhythm during ablation. The no-reinducibility of flutter should also be searched and it is useful to 
document bidirectional block in the isthmus during sinus rhythm (Fig. 21 and 22). In fact, according 
to some Authors [89], the latter would have the best predictive value for no-recurrence in the follow 
up. 
Both the anatomical and the electrophysiological techniques are characterized by success rates 
ranging from 70 to 90%. 
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Figure 20. Panel A. The triggering sequence of the tricuspid ring as is normally by stimulating from 
the postero-lateral region of the tricuspid (LRA). Catheters are placed on His (HBE) bundle, at the 
posterior side of the tricuspid (MC) and in the coronary sinus (CS). MC activates first, followed by 
HRE and CS (see also text) that are activated almost simultaneously. Panel B. Activation of the 
tricuspid ring by the stimulation of the postero-lateral region of the tricuspid after a linear lesion of 
the cava-tricuspid isthmus caused by radiofrequency. After ablation the tricuspid activates in 
clockwise direction, HBE atriogram is before CS. In MC you see a particular phenomenon. The 
catheter is positioned on the linear lesion and registers two wavefronts. The first (A) that reaches it in 
counterclockwise direction and the second (A') which proceeds in clockwise direction. A' follows the 
HBE atriogram. 
 
From: P. Delise. Le tachiaritmie sopraventricolari. Dall’elettrocardiogramma all’ablazione 
transcatetere. Ed. 1997. Casa Editrice Scientifica Internazionale. 
A 
B 
 
48 
 
 
Figure 21. Panel A. There is a catheter in the Hisan area (HBE, His Distal and Proximal), one in the 
postero-lateral side of the tricuspid (LRA) and one at the coronary sinus ostium (CS  3-4). Pacing is 
triggered by LRA during radiofrequency ablation. Two complexes are showed. Note that in the second 
complex the Stim-A interval in His-P remains constant. Conversely, in CS 3-4 the Stim-A interval 
increases from 100 to 135 msec. Also, while in the first complex the wave A in HBE and CS 3-4 is 
simultaneous, in the second complex CS 3-4 follows HBE. This delay is linkedto the constitution of 
a cava-tricuspid isthmus block.  
Panel B. Persistent common atrial flutter at the start of procedure of ablation of a cavo-tricuspid 
isthmus. 
From: P. Delise. Le tachiaritmie sopraventricolari. Dall’elettrocardiogramma all’ablazione 
            transcatetere. Ed. 1997. Casa Editrice Scientifica Internazionale.
A 
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Figure 22. Panel A. By delivering radio frequency from the ablation catheter, the flutter interruption 
isobtained. Panel B. After flutter interruption the atrium is stimulated by the catheter placed in the 
coronary sinus. Note that the Hisian region is activated firstly and later, with significant delay, the 
posterior-lateral region of the tricuspid (low lateral right atrium, LRA). The ablation catheter (MC) 
records two deflections of which the second one is inscribed after LRA. For the interpretation of this 
phenomenon refer to Figure 20. Panel C. After the flutter interruption, the atrium is stimulated by the 
catheter placed in the right posterior-lateral side. Note that the Hisian region is activated firstly and, 
later, the proximal coronary sinus (CS 4). The ablation catheter (MC) is activated after CS4. 
From: P. Delise. Le tachiaritmie sopraventricolari. Dall’elettrocardiogramma all’ablazione 
transcatetere. Ed. 1997. Casa Editrice Scientifica Internazionale.
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Indications. 
Typical CTI dependent AFL is a common arrhythmia that can cause significant symptoms and 
sequelae. The electrophysiological substrate underlying AFL is a combination of slow conduction in 
the isthmus of atrial tissue between the tricuspid annulus and the IVC and conduction block along the 
crista terminalis and Eustachian ridge. Because of the well-defined anatomic substrate, the 
disappointing results of AADs in treating AFL [90-93], and that data from clinical trials demonstrated 
that it may help to prevent hospitalizations [94,95], RF catheter ablation of AFL is a common 
procedure. Moreover, for patients undergoing AF ablation, creation of a CTI line can be performed 
safely, easily, and rapidly procedure time [96]. Guidelines for the treatment of AFL have been 
formalized as for AF, only in the last years [48,97,98]. According to the current recommendations 
[30,99,100], candidates for RF catheter ablation include (Class I) patients with AFL that is drug 
resistant, those who are drug intolerant, or those who do not desire long-term drug therapy. 
Antithrombotic therapy is recommended (Class I) using the same protocol for AF. Moreover, AFL 
ablation should be considered (Class IIa) in case of documented AFL in patients waiting AF ablation 
procedure (Fig. 23). 
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Figure 23. Recommendations for management of atrial flutter. 
From: ESC Guidelines for the management of atrial fibrillation developed in collaboration with 
EACTS.The Task Force for the management of atrial fibrillation of the European Society of 
Cardiology (ESC). Developed with the special contribution of the European Heart Rhythm 
Association (EHRA) of the ESC. Endorsed by the European Stroke Organization (ESO). European 
Heart Journal 2016;37:2893–2962. 
 
 
Outcome of Isthmus Block after Radiofrequency Ablation. 
 
Isthmus-dependent common AFL is the most frequent type of macro-re-entrant atrial tachycardia and 
the treatment of choice is RF catheter ablation with bidirectional conduction block across the CTI 
[11,13,14,85,101-105]. All the electrophysiologists presume that isthmus block is the end point of the 
radiofrequency ablation of the CTI. Poty et al. first described the criteria of isthmus block after 
ablation [103]. If isthmus block occurred, pacing at the proximal CS would show a complete 
descending activation of the low right atrium and pacing at the low right atrium would show a 
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complete descending activation of the septum. Tada et al. proposed double potentials along the 
ablation line as the criteria of isthmus block [106]. The time interval separating the two components 
of double potentials during a complete block was 135 ± 30 ms. The interval ≥110 ms was always 
associated with a local block. Isthmus block shifts direction of activation on the side of ablation line 
opposite from the pacing site, which changes an electrogram configuration. 
There are several modes of ablation of the CTI, including radiofrequency using conventional 4-mm 
tip, radiofrequency using large 8-mm tip, radiofrequency using cooled tip, and cryoablation. There 
were studies showing that the 8-mm-tip catheter was more effective than the standard 4-mm-tip 
catheter for ablation of the CTI. Feld et al. performed catheter ablation of type 1 AFL using large- tip 
electrode catheters and demonstrated an acute success rate of 93% and 97% patients had no recurrence 
of atrial flutter [107]. Furthermore, a meta- analysis study confirmed that cooled-tip and 8-mm large-
tip catheters was equally efficient for CTI ablation with both similar primary success rates and 
procedure parameters [108]. Cryoablation of the CTI, as compared with RF ablation, produced 
significantly less pain during application of the energy. Feld et al. performed cryoablation of the CTI 
and demonstrated an acute success rate of 87.5% and 90.2% of patients had no recurrence of AFL 
[109]. 
Ablation AFL outcomes are not always clear. Acute and chronic success rates have varied among 
studies, and the studies themselves differ in patient numbers, ablation technologies, and procedural 
end points. In addition, the occurrence of AF after AFL ablation may be a significant shortcoming of 
this procedure, but the reported incidence of AF after ablation varies widely [110-112]. Finally, 
important post-ablation outcomes such as mortality, AADs use, and anticoagulation use have not been 
well described. Thus, many long-term outcomes after AFL ablation are ill-defined. Generally, when 
AFL termination alone is used as an end point, the substrate for AFL recurrence is often left intact. 
Documenting bidirectional isthmus block reduces AFL recurrences by ensuring that all patients leave 
the laboratory with absence of the substrate for AFL. Termination of AFL without creating 
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bidirectional block was a common phenomenon during ablation procedures in the past. A meta- 
analysis [113] demonstrated a strong trend toward a higher procedural success with the more stringent 
end point of isthmus block. Moreover, the acute success rate was 92.7% when using large- tip or 
irrigated RF catheters, and the recurrence rate of AFL after ablation using large-tip or irrigated RF 
catheters and the end point of bidirectional isthmus block was 6.7%. In the same meta- analysis, the 
use of anticoagulation and AADs was common after AFL ablation. In fact, it was found ablation AFL 
increased AF recurrences. This should suggest that atrial electric disease may be less advanced in 
patients with AFL alone but is still progressive despite the prevention of flutter [111,112]. This finding 
was not confirmed by other studies limited, indeed, by a shorter follow up [94,114]. 
Contrary to catheter ablation of left atrial macro-reentrant tachycardia that it is more complex, with 
lower success rates and higher recurrence rates [115,116], the isthmus ablation is currently considered 
a simple procedure and far exceeds the efficacy of both pharmacologic therapy and DC cardioversion 
coupled with pharmacologic agents [117,118], with a success rate of about 75 to 90 per cent [80-
83,97,119-124], 90–97% in centers with extensive experience [125-127]. 
Nevertheless, ablation cannot be easily achieved in all patients, depending of the complex CTI 
anatomy. In these patients multiple energy applications and prolonged procedure times are required 
and the long- term recurrence rate varies from 5% to 12.9% [107-109,128-132]. 
 
 
Complications. 
 
AFL ablation has increased over the last decade, along with its associated major complications. 
Particularly, cardiac complications, such as pericardial effusion, cardiac tamponade, myocardial 
infarction due to right coronary artery injury, complete AV block requiring pacemaker implant, are 
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most common during AFL ablation. The distribution and frequency of complications are reported in 
Fig. 24. 
 
 
 
Figure 24. Distribution and frequency of complications after atrial flutter catheter ablations. 
From: Patel NJ, Deshmukh A, Pau D, et al. Contemporary utilization and safety outcomes of catheter 
ablation of atrial flutter in the United States: Analysis of 89,638 procedures. Heart Rhythm 2016; 
13(6):1317–1325. 
 
 
Patel et al [125] found that AFL ablations performed in patients >80 years of age was associated with 
a significantly higher number of complications (Fig. 25), perhaps because of comorbidities. 
Santangeli et al [133] reported no difference in total periprocedural complication rates between 
patients >80 years of age and <80 years of age undergoing AF ablation. This cohort is 
underrepresented in clinical studies to assess the efficacy and safety of AFL ablations, but it faces the 
maximum burden of AF and AFL, and outcomes in this cohort could possibly influence care in the 
future. 
Multiple studies have reported variable complication rates ranging from 0.8% to 6% and a mortality 
of rate of 0.1%. [134]. A meta-analysis by Spector et al. showed a complication rate of 4% and a risk 
of AFL ablation–related mortality rate of 0% [117]. In both of these studies, procedures were 
performed in high-volume academic centers. This probably contributed to the low mortality rates 
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seen. A single-center study from 2004 reported a major complication rate of 2.7% [130]. Another 
meta-analysis by Perez et al [113] showed an acute complication rate of 2.6%. Patel et al showed a 
complication rate of 3.17% and an in-hospital mortality of 0.17% obtained from hospitals across the 
United States [125]. A single-center study from France [135] found same results in complication 
rates. This trend of increase in complication rates may be attributable to an overall increase in the 
number of hospitals performing this procedure, resulting in a simultaneous decrease in hospital 
volume. In fact, both of two U.S. nationwide studies demonstrated an annual hospital volume of 

100 procedures/year was associated with a significantly fewer number of complications in 
comparison to an annual hospital volume of <50 procedures/year when adjusted for other 
confounding factors (Fig. 26) [125,136]. 
 
 
 
 
 
 
 
 
 
Figure 25. Overall complication rates of atrial flutter catheter ablation stratified by age group. 
 
From: Patel NJ, Deshmukh A, Pau D, et al. Contemporary utilization and safety outcomes of catheter 
ablation of atrial flutter in the United States: Analysis of 89,638 procedures. Heart Rhythm 2016; 
13(6):1317–1325. 
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The lowest-volume hospitals were also more likely to have a length of hospital stay longer than 2 
days. 
These results underscore the importance of having experienced high-volume centers, therefore, in 
addition to age and comorbidities, hospital volumes have strongly emerged as a factor predicting 
adverse outcomes. Since most ablations are performed in low-volume centers, appropriate measures 
are needed to determine a volume threshold considered optimum to control the utilization of this 
procedure at lower-volume centers, thus enhancing its safety. 
A multidisciplinary approach involving electrophysiologists, nurses, and technicians, in an 
environment with appropriate training of the supporting staff for early detection and adequate 
management of complications associated with ablation, also appears to be important. 
 
 
 
 
 
 
Figure 26. Spline curve illustrating the interaction among hospital volume and probability of the 
composite endpoint of mortality and complications after catheter ablation of atrial flutter. 
From: Patel NJ, Deshmukh A, Pau D, et al. Contemporary utilization and safety outcomes of catheter 
ablation of atrial flutter in the United States: Analysis of 89,638 procedures. Heart Rhythm 2016; 
13(6):1317–1325. 
 
Moreover, the establishment of RF catheter ablation techniques of CVI as the mainstay in the 
treatment of AFL has renewed new interest in cardiac anatomy. The interventional arrhythmologist 
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has drawn attention not only to the gross anatomic details of the heart but also to architectural and 
histological characteristics of various cardiac regions that are relevant to the development or 
recurrence of tachyarrhythmias and procedural related complications of catheter ablation. 
 
 
IMPACT OF THE CAVOTRICUSPID ISTHMUS ANATOMICAL FEATURES ON 
OUTCOMES AND COMPLICATIONS 
 
Despite very high success rates and almost no complications [137], ablation of the CTI can be 
extremely difficult in some patients with atypical anatomical conditions; the CTI anatomy is complex 
and associated with a significant inter-individual variability [16,17,20]. Knowledge of the detailed 
anatomy of this region can significantly improve the safety and success rate of ablation procedures. 
The morphology and muscular architecture of the CTI in the human heart, regardless of its relevance 
to clinical practice, is not yet fully understood. There have been only a few anatomical studies on this 
topic, and only three of them comprehensively investigated the majority of CTI dimensions [16-
18,138,139]. 
Autopsies, angiographic, and echocardiographic studies confirmed that the anatomy of AFL CTI is 
highly variable [16,140,141]: patients with a short and straight CTI require fewer radiofrequency 
ablation applications and shorter X-ray exposure. In study of cadaveric hearts the CTI was divided 
into three parallel levels [16, 18]. With the heart in attitudinal orientation, three levels of the isthmus 
were identified: paraseptal, inferior, and inferolateral. The paraseptal isthmus forms the base of 
Koch’s triangle and is commonly referred to as septal isthmus. The septal isthmus is the shortest of 
the three isthmuses but has the thickest wall on heart specimens and it is closest to the AV node, 
particularly the inferior nodal extensions. The inferior isthmus, also known as the “central isthmus” 
owing to its location between the other two isthmuses (6 o’clock on LAO), represents the optimal 
target for ablation since this is the thinnest site between the ICV ostium and the tricuspid valve 
annulus. It is also shown that most lengths of isthmus are larger in patients with permanent AFL 
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compared to paroxysmal AFL or control groups [142].  The inferolateral and central isthmuses, 
despite they are longer, are considered to be better places than paraseptal isthmus for ablation, in 
order to avoid complications [143]. In fact, ablation at the paraseptal isthmus is associated with a 
significant risk of AV node injury and conduction block. Additionally, the paraseptal region has the 
thickest muscular content among the CTI. Therefore, it is not a preferable target for ablation. In 
cadaver hearts, all three isthmuses have in common a smooth anterior zone being the right atrium 
vestibule. By contrast, the posterior zone is composed of mainly fatty tissue as it joins the Eustachian 
valve. Between the anterior and posterior zones, the morphology and thickness of the isthmus are 
highly variable. 
The crista terminalis is also important in AFL. The final ramifications and its non-uniform pattern 
seems to play a role in the propagation of impulses and has an impact on the success rate of CTI 
ablation [144]. Ablation of significantly thicker crista terminalis in lineal CTI ablation may 
necessitate increased radio-frequency energy and be the cause of procedural failure. 
Obstacles such as a large Eustachian ridge/valve or a deep sub-Eustachian sinus may also lead to 
longer and more difficult ablation sessions [145]. These parameters may hinder catheter access to the 
regions located anterior to the ridge and valve. Also, the Eustachian ridge, due to the presence of 
muscle fibers, is able to conduct electrical impulses and represents the site of conduction gaps that are 
difficult to ablate. In these cases, only the complete abolition of the Eustachian ridge using more 
powerful ablation catheters results in complete bidirectional isthmus block [22]. Moreover, for the 
electrophysiologist entering the right atrium via the inferior route, the first structure encountered is 
the Eustachian valve guarding the ostium of the ICV. Normally, it is a thin, insignificant. 
Occasionally, it is large and may impede access to the most posterior part of the isthmus. The free 
border of the Eustachian valve continues as the tendon of Todaro that runs in the musculature of the 
Eustachian ridge. It has been demonstrated that, in patients with a large Eustachian ridge/valve, the 
paraseptal isthmus block can be obtained only after the complete ablation of the enlarged Eustachian 
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ridge [23].  In approximately 2% of the population,  the Eustachian valve  has a strange appearance 
of varying size. It is known as a Chiari network and when electrophysiologists encounter it, they 
should be aware of the potential risk of the catheter being caught by the network [146]. 
Indeed, ablation difficulties are typically caused by tissue thickness, pouches or muscular bridges or 
trabeculae [147]. In the study of Cabrera et al. [16], in the vast majority of cases (83%) the central 
isthmus traversed through a recess that is termed the “subeustachian sinus.” It is a relatively large 
pouch-like recess measured with a depth of 3–5 mm.  
n the majority of specimens, the pouch was membranous (63%, 19 hearts), with scarce muscular 
fibers. The presence of sub-Eustachian recesses significantly prolongs ablation time and is associated 
with a higher risk of complications and a lower rate of success [148]. These recesses are always found 
slightly to the right of the CS ostium and are never found in the lateral third of the CTI. As a result, 
the ablation line may be performed more laterally to avoid recesses [137]. Other authors found 
intertrabecular recesses and trabecular bridges laterally to the sub-Eustachian recesses located in the 
middle CTI sector [149]. Their transverse arrangement in relation to the long CTI axis (perpendicular 
to the septal leaflet attachment point) may contribute to enter the catheter between the tissue bridge 
and the thin atrial wall. The gaps between the bridges and the proper atrial wall may negatively 
influence the ablation, and more energy may be required to reach the isthmus block. 
In anatomical studies with CT scan is seen, a “hook-shaped” morphology, showing a concave or 
pouch-like segment posteriorly (at the ICV side) and a vestibular part anteriorly in around 28% of the 
population [20]. 
The sub-Eustachian recess is an extension of a pouch-like isthmus under the CS ostium. The presence 
of a large sub-Eustachian recess or deep pouches is associated with significantly more RF applications 
and complications as compared with straight isthmus. Local radiofrequency delivery may be impaired 
by this structure because an area of limited blood flow results in delayed catheter tip cooling. In one 
angiographic study of the CTI, this pouch was observed in 47% of patients [140]. CT scans in normal 
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population have identified a deep recess combined with a pouch-like (greater than 5 mm in 45% of 
patients) central isthmus in 45% of mid-diastolic phase images [20]. This finding would be useful in 
preprocedural planning, where the presence of a large pouch would dictate a central approach to the 
ablation. 
The majority of anatomical obstacles are unfortunately detected only at the time of CTI ablation, 
which significantly prolongs the procedure time, reduces the success rate, and increases 
complications. 
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Part II. 
THE ANATOMICAL FEATURES OF RIGHT ATRIAL 
CAVOTRICUSPID ISTHMUS CAN IMPACT RADIOFREQUENCY 
CATHETER ABLATION IN TERM OF SUCCESS RATE AND 
COMPLICATIONS 
 
 
BACKGROUND AND OBJECTIVES 
Radiofrequency (RF) catheter ablation targeting the isthmus between the tricuspid annulus and the 
inferior vena cava (IVC) is the established treatment for typical atrial flutter (AFL) for its high 
efficacy. Despite this high success rate, more than 90% [11,12,103,126,150-152], ablation can be 
extremely difficult, due to great inter-individual variability of the cavotricuspid (CTI) anatomy. In 
fact, in the clinical setting, these anatomical features are associated with prolonged procedure times, 
increased total amount of radiofrequency energy, and reduced success rates [140,148,153,154], 
beyond catheter technology used. Pounce-like recesses and CTI length might be the reasons of 
majority of these problems. 
The aim of this study was to assess how and why complex CTI anatomy influences ablation 
procedure. Primary endpoint was to evaluate the impact of the underlying CTI anatomy on acute and 
long-term success rate which is defined by achieving a consistent bidirectional block as protection for 
recurrence of AFL. Secondary endpoint was to determine any ablation related complication and 
procedure time. 
At the same time, we analyzed the anatomy of the CTI region in autopsy hearts in order to find out 
the presence of any recesses, their number and position and their histology. 
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METHODS 
 
Study population. 
 
A total of 337 consecutive symptomatic patients underwent RF catheter ablation for recurrent typical 
counterclockwise AFL and were included in this prospective analysis between April 2013 and 
October 2017. 
Exclusion criteria were as follows: (1) absence of informed patient consent; (2) age <18 years; (3) 
AFL recurrence after a previous ablation session, both AFL or atrial fibrillation (AF); and (4) 
pregnancy. 
Typical AFL was identified by predominantly negative flutter waves in leads II, III, and aVF and 
positive in lead V1, with a regular atrial rate between 240 and 340 bpm, as the documentation during 
standard ECG or Holter ECG monitoring. AADs treatment was discontinued at least fifteen days 
before hospital admission in case of amiodarone, four half-lives before if class IC drug. For patients 
already receiving oral anticoagulation, this was withdrawn two days prior to the procedure to obtain 
an international normalized ratio of < 2.0 during the procedure, or 24-36 hours before in case of new 
oral anticoagulant (NAO). Venous thromboses were systematically prevented by subcutaneous low-
molecular-weight heparin administrated after CTI ablation. 
Transthoracic two-dimensional imaging combined pulsed Doppler echocardiography were performed 
before ablation in all patients. Left ventricular ejection fraction was determined by calculating the 
end diastolic and end systolic volumes. Left atrial size was measured at end systole in the parasternal 
long axis view. 
 
Electrophysiological Study and Mapping. 
 
All procedures were performed in the fasting state, under conscious sedation using boluses of 
midazolam and fentanyl and local anaesthetic were used to make it comfortable and virtually painless. 
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Vital parameters such as arterial blood pressure and oxygen saturation were monitored throughout 
the entire procedure. All standard ECG leads were recorded continuously throughout the procedure 
to facilitate rapid review, however only leads I, II, and V1 were displayed in real time. Leads I, II, 
and V1 were filtered through a 1 – 500 Hz bandpass filter, whereas bipolar intracardiac electrograms 
from all catheters used were acquired with a filter bandwidth of 30 - 500 Hz and amplified at high 
gain (0.1 mV/cm). The recording displayed at a sweep speed of 150 msec and the stimulation with a 
2-ms output pulse width set at 4 times the threshold amplitude were performed using a cardiology 
monitoring system (Manta Electrophysiology). 
Firstly, one 5F decapolar catheter (5F Supra CS catheter, Biosense Webster) was placed through left 
brachial vein, within the coronary sinus (CS) with the proximal electrode pair positioned at the ostium. 
Hence, two catheters were introduced through the right femoral vein into the right atrium. This 
allowed the insertion and movement of the catheters up into the heart under X-ray guidance, in 
particular one 7F 20 electrodes catheter (Livewire Duo-Decapolar, St. Jude Medical) that was placed 
anterior to the crista terminalis at the right free wall close to the tricuspid annulus and an 8F/8-mm-
tip electrode deflectable catheter (Blazer II XP, Boston EP Technologies) used as mapping/ablation 
catheter in all patients. 
Fluoroscopic examination during catheter-electrode mapping and ablation procedures was usually 
performed using frontal and oblique projections. We used the frontal view to introduce and position 
catheters in the right ventricular apex and in lateral free wall of the right atrium. Left anterior oblique 
(LAO) projection, a 45-degree tilt, was generally used to catheterize the CS. 
 
Coronary sinus activation sequence. 
 
If the patient was in AFL at the time of the procedure, AFL was diagnosed when the intracardiac 
electrogram, displayed the following activation sequence: high right atrium then low right atrium, a 
counterclockwise IVC–tricuspid isthmus activation sequence followed by left atrial activation 
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established with the decapolar catheter. Therefore, the CS activation sequence was always from 
proximal to distal (Fig. 27). Together with the typical ECG findings, a proximal-to-distal CS 
activation sequence was not considered diagnostic for, but rather was believed highly suggestive of 
CTI-dependent flutter as the underlying tachycardia mechanism. 
 
 
Figure 27. Coronary sinus (CS) activation sequence is always from proximal to distal in typical atrial 
flutter. It is possible to see a continuous potential recorded by ablation catheter. 
 
 
 
  Endocardial mapping. 
 
Once the diagnosis of CTI-dependent flutter was suspected from the surface ECG and the CS 
activation sequence, more detailed intra-atrial mapping was performed. Using the CS as a stable 
reference, putting mapping/catheter ablator approximately within the right atrium and around the 
tricuspid annulus, the direction of impulse propagation during tachycardia was evaluated. For the 
majority of patients with CTI-dependent counterclockwise flutter, the atrial electrogram recorded on 
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the mid-isthmus lies within the plateau phase of the flutter wave. 
Concealed Entrainment and Post Pacing Interval. 
 
As we know, entrainment can be employed in the right atrium and CS, to confirm and exclude the 
right and left atria as the chamber of arrhythmia origin respectively [5,56,105]. Entrainment involves 
pacing from multiple, separate sites within the right atrium at cycle lengths of 10-20ms faster than the 
tachycardia cycle length, observing its effect on flutter wave morphology and estimating proximity 
of pacing site to tachycardia circuit by analysis of the post pacing interval (PPI). The pacing site is 
considered to lie within the tachycardia circuit when the PPI is within 30 mses of the tachycardia 
cycle length. Entrainment from sites which are outside the flutter circuit will demonstrate manifest 
fusion on the surface ECG and the PPI will exceed the flutter cycle length by more than 30 msec. In 
our study, if the patient was in AFL, an isthmus participation in the arrhythmic circuit was 
demonstrated by entrainment maneuvers (concealed entrainment in the isthmus) (Fig. 28). 
Many patients with a history of AFL who were been referred for ablation procedure were in sinus 
rhythm at the time of their procedure. If the 12 leads electrocardiogram recorded during the clinical 
arrhythmia was consistent with CTI-dependent flutter, and the medical history gave no cause to 
suspect a left atrial origin, RF ablation of the CTI directly was performed. No attempt AFL induction, 
but preserved bidirectional isthmus conduction was only verified under stimulation from proximal 
pole of CS catheter.
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Figure 28. Endocardial electrograms from the RF, Halo, CS, and His bundle catheters, and surface 
ECG leads I, aVF, and V1, demonstrating concealed entrainment during pacing at the CTI in typical 
AFL (A) and reverse typical AFL (B). Halo D-Halo P, bipolar electrograms from the distal to 
proximal poles of the Halo catheter around the TVA; CSP-D, bipolar electrograms recorded from the 
proximal to distal CS catheter electrode pairs; HISP&D, bipolar electrograms recorded from the 
proximal and distal His bundle catheter; RFAP&D, bipolar electrograms recorded from the proximal 
and distal electrode pairs of the mapping/ablation catheter at the CTI. 
From Feld GK, Srivatsa U, Hoppe B. Ablation of isthmus dependent atrial flutters. In: Huang SS, 
Wood MA, editors. Catheter ablation of cardiac arrhythmias. Philadelphia: Elsevier; 2011. 
 
 
Radiofrequency Catheter Ablation. 
Ablation was performed in the patient’s presenting rhythm, be it flutter or sinus rhythm. In the case 
of the latter, continuous pacing was performed from the proximal pole of the CS (cycle length 600 
msec) as this location is more stable than a pacing catheter positioned in the inferolateral right atrium. 
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RF delivery using 8mm tip ablation catheter was applied point-by-point. Ablation was started at the 
tricuspid annulus site (the CTI end) when a stable electrogram with a small atrial and large ventricular 
amplitude was observed (a:V electrogram amplitude ratio was of ~1:2). The ablation catheter was 
placed at 6 o'clock position and was pulled back using a drag technique from the tricuspid annulus to 
the inferior vena cava (IVC), applying energy for up to 60 seconds at each successive ablation point. 
The catheter was carefully moved after each application, under fluoroscopic guidance, to produce as 
much as possible a linear lesion with contiguous RF points until the IVC was reached. LAO projection 
was used to pull back the catheter from tricuspid side until the mid-isthmus, hence frontal projection 
was preferred to reach the IVC. RF energy was delivered through the EPT-1000 Cardiac Ablation 
System Controller (EP Technologies, Inc.) with a power limit of 70W and a target temperature of 
60°C. 
The procedure end point was defined as a complete bidirectional isthmus block between the tricuspid 
valve (TV) and the IVC (posterior isthmus) described elsewhere [14,103,104,152]. 
The presence or absence of bidirectional isthmus conduction block was assessed during pacing from 
the CS ostium (Fig. 29) and low lateral right atrium at a cycle length 600 msec while performing RF 
delivery over the line. As it is known, a craniocaudal activation of the septum (proximal CS pole 
activated after His bundle region) during pacing of the low lateral right atrium indicates a 
counterclockwise block in the isthmus, whereas a craniocaudal activation (low after high right atrium) 
of the lateral right atrium during pacing of the proximal CS indicates a clockwise block. We searched 
for a reversal of the right atrial depolarization sequence established by a complete cavotricuspid map 
using a multipolar mapping catheter straddling the line of block [155]. We also looked for widely 
separated local double potentials (an isoelectric interval >100msec) along the ablation line 
[106,156,157], during atrial pacing [151,152] (Fig. 30 e 31). 
When signs of conduction block were observed during RF application with proximal CS pacing, one 
extra RF application lasting 1 minute was performed at that site, again. In patients with AFL, 
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ablation was continued also after AFL interruption was obtained during RF application. Ablation was 
continued until isthmus block was achieved (Fig. 32). 
The persistent status of the bidirectional block was assessed continuously over the 30-minute period 
after bidirectional block occurrence. On occasion, conduction resumed after ablation. A complete RF 
ablation sequence was reinitiated until the bidirectional block was observed again, resetting the 30-
minute waiting period. 
A cumulative time of RF delivery defined as the time [min] to achieve bidirectional CTI block, 
measured from the first RF application was recorded, and procedure time defined as skin-to-skin total 
time spent for procedure, including time to search for venous approach, catheter positioning and RF 
ablation, proof of bidirectional block, maneuvers to delineate the patient's CTI anatomy were 
calculated. 
 
 
Figure 29. The presence or absence of bidirectional isthmus conduction block was assessed during 
pacing from the coronary sinus ostium (purple). It is possible to see a continuous potential recorded 
by ablation catheter (red), again. 
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Figure 30. During pacing from the coronary sinus ostium (purple). It is possible to see a continuous 
potential recorded by distal electrode ablation catheter (gap), and a narrow double potential recorded 
by proximal electrode ablation catheter (red). 
 
Figure 31. Bidirectional isthmus conduction block assessed during pacing from the coronary sinus 
ostium (purple). Note reversal activation of the right atrial depolarization sequence recorded by 
multipolar mapping (blue). It is possible to see widely separated double potentials recorded by ablation 
catheter (red).
 
71 
 
 
Figure 32. Surface ECG leads I, aVF, and V1 and endocardial electrograms from the coronary  sinus 
catheter (CSP-D), the ablation catheter (CARTO P&D), and power, impedance, and temperature 
readouts, show termination of AFL and restoration of sinus rhythm immediately after initiating 
ablation near the tricuspid valve annulus. 
From: Huang SS, Wood MA, editors. Catheter ablation of cardiac arrhythmias. Philadelphia: 
Elsevier; 2011.) 
 
 
Cavotricuspid Isthmus Anatomy Classification. 
Previous anatomic and angiographic reports studying human hearts have pointed to the anatomic 
variability of the isthmus, reporting a variable width and different morphologies of CTI [18,19,140]. 
Some authors revealed variable isthmus anatomy makes the catheter ablation a difficult task and they 
advised to adjust strategy for improving its efficacy and safety [148]. In particular, the presence of 
Eustachian valve or concave isthmus was associated with statistically more RF applications, and the 
same trend was seen for patients with deep pouches [140]. 
In our study, CTI was classified into groups: (A) simple (flat) CTI, (B) complex (pouch-like recess 
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or concave shape) CTI, according to anatomy features found during ablation procedure. During 
procedure, additional pull back maneuvers were performed septally and laterally to the initial line of 
ablation to further delineate the patient's CTI anatomy. The CTI length was measured as the shortest 
linear distance between the lower hinge point of the tricuspid annulus and the IVC using frontal 
fluoroscopic projection. We carefully looked for deep recesses in order to assess their position along 
CTI. Procedures were classified as "difficult" if we found deep recesses. All remaining procedures 
were considered as "easy". 
Follow-Up. 
After the hospital discharge, usually next day, Class I or III AADs were prescribed to all patients with 
previous concomitant AF. Aspirin 160 mg was administered for four weeks unless systemic 
anticoagulation with warfarin or NAO was indicated. In this case warfarin continued to be 
administered for at least four weeks. 
Outpatient follow up included 12-lead ECG, and Holter ECG monitoring, scheduled at months 3, 6, 
and 12. Patients were encouraged to contact one of the physicians if they experienced recurrent 
palpitations. 
 
 
ANATOMY STUDY 
 
We examined 104 formalin-fixed hearts from patients who underwent routine clinical autopsy 
performed at the Cardiovascular Pathology Unit, University of Padua. The exclusion criteria 
corresponded to severe alteration of the heart specimen due to preexisting pathologies or inadequate 
preservation/dissection technique. The cause of death was primary cardiac in almost half of the 
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population (47% of patients), but only the cases in which the pathology did not involve the right 
ventricle were selected. 4 patients (3,8%) had a history of atrial flutter and were analyzed separately. 
 
Macroscopic analysis. 
 
The gross examination of the cardiac specimen in every clinical autopsy at our Center is performed 
according to the minimum standard required in the routine autopsy practice for the adequate 
assessment of cardiac death in the general population [158]. Focusing on the right side of the heart, 
the superior vena cava is transected 2 cm above the point where the crest of right atrial appendage 
meets the superior vena cava (to preserve sinus node), while the inferior vena cava is transected close 
to the diaphragm. The right atrium is opened from the inferior vena cava to the apex of the right atrial 
appendage. Once emptied of blood, the total heart weight is assessed. At the end of the diagnostic 
procedure, the hearts are fixed in 10% neutral buffered formalin solution. In order to display the area 
of interest, the right atrium was opened by cutting the anteroposterior commissure of the tricuspid 
valve along the acute margin. The CTI is a quadrilateral area of the right atrial wall bounded 
posteriorly by the Eustachian valve and ridge, medially by a line traced between the superior extent 
of the ridge of the Eustachian valve and the tricuspid orifice at the base of the triangle of Koch 
superomedially (the so called paraseptal isthmus), anteriorly by the septal tricuspid leaflet attachment 
and laterally by a line from the terminal crest to the right end of the septal leaflet (the so called 
inferolateral isthmus). The vertical line dividing this quadrilateral area in two almost symmetrical 
parts is the central isthmus [18,149] (Fig. 33). Every heart was examined by two independent expert 
cardiovascular pathologists. The following features were assessed: 
1. The length of the central isthmus 
2. The presence of pouch-like recesses 
3. The number of the pouch-like recesses 
4. The position of the pouch-like recesses 
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Figure 33. (A) Schematic view of the CTI region. (B) Photograph of a heart specimen in which the 
area of interest is highlighted. IVC, inferior vena cava; FO, foramen ovale; CS, coronary sinus; TV, 
tricuspid valve; R, recess. 
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           Histological analysis. 
The CTI was subdivided into three segments (from the Eustachian ridge to the tricuspid valve 
attachment): the posterior, the middle and the anterior sector (Fig. 34). Full thickness samples of the 
right atrial wall were taken in a sagittal plane, including the three sectors, at three different levels (the 
two lateral borders of the CTI and the central isthmus), as previously described [16]. The blocks were 
then processed for histological examination. The paraffin-included sections (5 µm thick) underwent 
serial cutting, deparaffinization and staining by hematoxylin-eosin and Heidenhain trichrome. 
Histological sections stained by Heidenhain trichrome were observed at light microscope (Olympus; 
BX51 lenses) at different magnifications and after digitally acquired in .jpeg format. At every level 
(inferolateral, central and paraseptal isthmus), the distance from epicardium to endocardium was 
measured in every sector (posterior, middle and anterior). The distance from the endocardium to the 
right coronary artery was also measured. The morphometric analysis was performed with an image 
analyzer system and a commercially available software (Image-Pro Plus Version 4.0, Media 
Cybernetics, MD, USA). Two observers, blind to clinical data, performed the morphometric analyses. 
 
Figure 34. Histological section of the inferolateral isthmus of an illustrative case. The three sectors of 
the CTI (posterior, middle and anterior) are indicated. The myocardial thickness is measured at these 
three levels. The minimal distance between the adventitia of the right coronary artery and the 
endocardium is also assessed (*). TV, tricuspid valve; RCA, right coronary artery. Heidenhaim 
trichrome stain. Scale bar = 1 mm. 
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Statistical Analysis. 
 
 
Continuous variables were expressed as mean ± standard deviation. Discrete variables are presented 
as absolute and percentages. 
Categorical variables were compared by Chi-Square Test. The comparison between patients 
underwent ablation who had a simple CTI anatomy and those had a complex anatomy groups were 
analyzed by Student’s unpaired (two-sample) t test for continuous variables. A probability value 
<0.05 was considered as statistically significant. 
 
The same statistical analysis was used for both ablation and anatomy data. 
All analyses were performed by the Stata software version 11.0. 
 
 
RESULTS 
 
ABLATION 
Patients' characteristics. 
Over a period of 54 months, a total of 337 patients underwent first time AFL ablation. Mean age of 
all patients was 62.8 ± 10.6 years (range 28 - 84), male was 236 (70%). Structural heart disease was 
present in 186 of 337 patients (55.2%). Hypertensive cardiomyopathy in 134 (39.8%) and ischemic 
heart disease in 29 (8.6%) were the most frequent diseases. Two hundred and thirty two of the 337 
patients (68.8%) had a history of AFL and AF. Before ablation, 64 (19%) patients were on amiodarone 
therapy, 163 (48.4%) were on class IC drugs (propafenone and flecainide) therapy. In 93 patients 
(27.6 
%) of the latter group, drug converted AF into AFL.  One hundred and sixteen (34.4%) used warfarin 
and 93 (27.6%) used NAO. External electrical cardioversion had been performed in 64 patients (19%) 
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because they had previously decided not to accept ablation at first. Tab. I summarizes clinical baseline 
patients characteristics. 
 
 
 
 
 
 
 
 
 
 
 
 
 CTI A 
(Simple, Flat) 
n=300 
CTI B 
(Complex, with Recesses) 
n=37 
P value 
Age (years) (mean ± SD) 
range 
63.5±9.7 
42-84 
59.6±14.2 
28-76 
NS 
Left Atrial Size (mm) (mean ± SD) 
range 
39.1±7.6 
30-52 
37±12 
32-50 
NS 
EF (%) (mean ± SD) 
range 
62.1±7.4 
56-69 
64.1±4.5 
59-70 
 
NS 
 
 
Table I. Clinical baseline patients characteristics. EF, Left Ventricle Ejection Fraction. 
 
 
 
Radiofrequency catheter ablation. 
Total mean CTI length was 23.3 ± 3.9 mm (range 10 – 35 mm). Deep recesses were found in 37 
patients (10.9%), males were 24 (64.9%). Recesses finding was not related to aging, gender, left atrial 
size, and left ventricle ejection fraction (p=NS). On the contrary, CTI length was shorter in type A 
anatomy as compared to type B (22.9 ± 3.2 vs 25.6 ± 6; p = 0.01). 
The primary endpoint of efficacy defined as bidirectional CTI block, was reached in 99.4% (335/337) 
of cases with no difference between groups. Acute ablation failure (n = 2 patients) was associated 
with type B CTI anatomy. There was no difference in procedure success among the different three 
operators (p = NS). Total mean radiofrequency application time for all procedures was 8.7 ± 3.7 
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minutes (range 3 – 25 minutes). The amount of radiofrequency application time, to achieve 
bidirectional isthmus block, during the procedure was significant shorter in type A CTI anatomy as 
compared to type B (8.3 ± 3 min vs 10.7 ± 6 min; p = 0.025) respectively; that demonstrates ablation 
is more difficult in case of complex anatomy. 
Regard to the secondary endpoints, complication occurred in 1 patient (0.29%) with the CTI type B 
anatomy: a steam pop immediately followed by cardiac tamponade required urgent pericardiocentesis 
that solved complication. 
Total mean procedure time was 51.6 ± 14.4 minutes, no statistically difference between two groups 
(p = NS). Tab. II shows procedure and ablation parameters for each group. 
 
 
 
 
 
 
 
 CTI A 
(Simple, Flat) 
n=300 
CTI B 
(Complex, with Recesses) 
n=37 
P value 
CTI Length (mm) (mean ± SD) 
range 
22.9±3.2 
      10-29 
25.6±6 
10-35 
0.01 
RF Application Time (min) (mean ± SD) 
range 
8.3±3 
        3-17.8 
10.7±6 
 4.6-25 
0.025 
Procedure Time (min) (mean ± SD) 
range 
50.4±14.2 
      20-110 
57.3±14.5 
30-90 
NS 
 
 
Table II. Procedure and ablation parameters. 
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Follow-Up. 
After a mean follow-up time of 36.7 ± 17.2 months (range 4–54 months), 99.7% (334/335) of patients 
were free of AFL recurrences. Typical AFL recurred in 1 symptomatic patient with CTI type B 
anatomy. AFL was documented at 24 hours Holter ECG monitoring and 12 lead ECG. The patient 
underwent second ablation procedure. Conduction across the ablation line was demonstrated. 
Successful ablation was performed. No new recurrences have occurred until this time. 
At the end of follow up 184 of 335 patients (54.9%) were treated with AADs; 39 (11.6%) patients 
with amiodarone, 145 (43.3%) with flecainide. 
 
 
ANATOMY 
 
The mean age of the individuals was 67 ± 17 years, with a male prevalence (65%). The mean heart 
weight was 457 ± 102 g. The length of the central isthmus was 24 ± 4.1 mm (range 15 - 38 mm) 
without differences between groups (24.1 vs 23.6, p = NS), respectively. The central isthmus in the 
patients affected by atrial flutter was significantly longer compared to the other cardiac specimens (p 
< 0.01). In 10 of our cases (9.6%), a sub-Eustachian recess was present. As in the clinical series of 
patients undergoing ablation, the presence of recesses was not related to aging and gender. The recess 
was single in the majority of cases (60%) and the most frequent location was the central isthmus 
(60%). In the 4 cases diagnoses with atrial flutter, no recess was found in the CTI. The highest number 
of recesses found in one specimen was 3 (Fig. 35).  
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Figure 35. Photograph of hearts in which one and more recesses were found. * , coronary sinus; 
Black arows, recesses
*
*
*
*
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The examination of the myocardial thickness at the different levels is displayed in Tab. III. The 
regions with the thinnest muscular wall resulted to be the anterior and middle paraseptal and middle 
central. 
 
 
 
Sector  
Level Posterior Middle Anterior 
Inferolateral (mean ± SD) 
range 
3.0 ± 2.4 
1.2 – 6.5 
1.7 ± 1.3 
0.2 – 2.8 
2.5 ± 0.4 
2.3 – 3.1 
Central (mean ± SD) 
range 
1.9 ± 1.7 
0.7 – 4.3 
1.0 ± 0.9 
0.1 – 2.2 
2.1 ± 0.8 
1.5 – 3.3 
Paraseptal (mean ± SD) 
range 
2.6 ± 1.8 
0.9 – 5.1 
1.0 ± 1.2 
0.2 – 2.7 
0.9 ± 0.8 
0.2 – 1.9 
 
 
 
Table III. Mean myocardial thickness (mm) across the three different levels and three sectors of the 
CTI. 
 
The assessment of the distance between the endocardium and the right coronary artery is described in  
Tab IV and the sizes, diameter and area, of recesses in Tab V. 
 
Level Distance 
 
Inferolateral (mean ± SD)  6.2±2.5  
      range          3.7-8.4 
 
Central (mean ± SD)  6.1±3.6 
                 range  0.9-8.7 
 
Paraseptal (mean ± SD)  4.0±2.6 
                 range  0.7-4.5 
 
 
 
 
 
Table IV. Mean minimal distance (mm) between endocardium and right coronary artery. 
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 Number of 
recesses 
Diameter (mm) Area (mm2) 
Case 1 3 2.1                   
3.1                   
3.7 
 1.6 
 3.2 
            4.9 
Case 2 1 8.4 47.5 
Case 3 2 5.4                   
14.6 
11.0                                 
115.7 
Case 4 1 3.7 9.6 
Case 5 1 2.5 3.3 
Case 6 1 11.5 73.1 
Case 7 1 16.5 41.4 
Case 8 1 15.3 103.2 
Case 9 2 3.4                   
2.9 
4.6                                      
3.6 
Case 10 1 3.7 6.7 
 
 
Table V. Sizes of recesses. 
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DISCUSSION 
 
This study investigated the relationship between CTI anatomy and AFL ablation and confirms that 
catheter ablation of typical AFL involving the CTI is a safe, effective, and well-established ablation 
procedure. Nevertheless, as other papers reported, it appears that the CTI anatomy impacts ablation 
parameters and that is why ablation can become difficult in some patients, depending of their complex 
CTI anatomy that influences inevitably ablation outcomes. In particular, the reported complex 
anatomy typically addresses tissue thickness, pouches or muscular bridges or trabeculae [23, 147], 
but especially pouch-like recess and/or long CTI. All these features are associated with reduction of 
success rate and with prolonged procedure time, increasing ablation complications. More RF energy 
applications and a prolong fluoroscopy time are needed in patients with complex CTI morphologies 
[153-154]. 
In our study, both CTI length and characteristics, such as the presence of pouch-like recesses, were 
factors associated statistically with more RF applications. In other words, with a more difficult 
ablation. Nevertheless, the procedure time was not different between groups. Moreover, it is important 
to mention that the acute success rate, defined as bidirectional block achieved during the ablation 
procedure, was high in both group, the duration of the procedure was about equal and the arrhythmia 
recurrence rates were very low, as well. In our series, although small numbers, we cannot ignore all 
(2) ablation failures and all recurrences (1) were associated with a complex CTI anatomy. 
This finding leads basically to some considerations: 
 
1)  electrophysiologists should have appropriate anatomic knowledge and relevant experience. 
 Knowledge of the detailed anatomy of CTI region can significantly improve the safety and 
 success rate of ablation procedures. 
2) Sub-Eustachian recesses are common findings with a prevalence reaching 47-80% 
[16,20,140,149]. In our series, the recesses prevalence was 10.9% in ablation population and 9.6 
% in anatomy study. The apparent disparity with the previous series published in the literature 
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found an explanation in the different definition of recesses. In fact, we focused the attention on 
those “pouch-like” since they are likely to represent an obstacle to catheter ablation. Noteworthy, 
our anatomical data are confirmed by our electrophysiological data in different population. We 
found recesses at mid-isthmus and at the IVC side. We never found them at the TV side. Other 
authors found intertrabecular recesses and trabecular bridges laterally to the sub-Eustachian 
recesses located in the middle CTI sector [149]. Since the presence of sub- Eustachian recesses 
was associated with significant prolonged ablation time, and a higher risk of complications, with 
a lower rate of success [137, 148], evaluating their presence along CTI would be useful in 
planning ablation strategy. In our opinion, hence, search for recesses should become a common 
approach before starting of RF applications to adjust ablation goal in order to perform lesion line 
far from recesses. 
3)   Frequently, the area immediately anterior to the IVC ostium is composed mainly of fibrous and 
      fatty tissue, with minimal muscular fibers coursing through it. The clinical implication is that this 
      part of the CTI could need less RF energy to form lesion. 4) Actually, a non uniform terminology 
      exists between electrophysiologists and pathologists. Nowadays, a unique nomenclature should 
      be better find out, in order to favor dialogue among the specialists. A consensus in the terminology 
      should increase the comprehension and the collaboration finalized to improve work of each other. 
 
 
Clinical implications. 
The majority of anatomical obstacles in patients candidates to CTI ablation are unfortunately detected 
only at the time of procedure. The purpose of our study was to review the anatomy and 
electrophysiology of the CTI in order to improve acute and long-term outcome of RF ablation for the 
patients with AFL, despite the complexity of the anatomy. 
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We found that in patients with pouch-like recesses, the CVI is longer and more RF energy application 
is needed to achieve CTI block when compared with CVI simple. However, we cannot exclude that 
the thickness of the myocardium can influence the RF energy level.  
Look for the recesses within CTI may facilitate the choice of ablation technique. CTI anatomy and 
thickness should be better defined before starting ablation. That should lead to improve success rate 
and reduce the ablation complications. 
 
STUDY LIMITATIONS 
Ablation 
The primary limitation of our study is that a single center is involved. Another limit was that AADs 
were advised at the discharge to 54.9% patients having pre-ablation history of AF. Therefore, our 
results on post-ablation AFL recurrence do not reflect the pure effect of trans-isthmic ablation but 
rather the combination of pharmacological and ablative treatments in almost more half population. 
Furthermore, the effect of anatomy of the isthmus on fluoroscopy time was not among the considered 
variables. 
 
Anatomy 
The limitations of this study reside on the fact that all of the measurements were made on autopsied, 
structurally normal heart specimens that had been fixed in formaldehyde. This fixing might have 
resulted in some slight changes in the size and shape of the hearts. However, the use of 10% 
paraformaldehyde did not cause significant changes in the dimensions of the atrial tissue; the 
dimensions of fixed hearts are similar to those that are unfixed. In our study we revealed, in a real 
world scenario, that length of CTI was shorter in patients with simple CTI (group A) than in patients 
with complex CTI (group B). These data have not been confirmed by analysis on the autopsy hearts, 
perhaps for reasons described above or for a low number of hearts examined. 
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CONCLUSIONS 
Our electrophysiological and anatomical study has provided relevant information to clinical practice. 
Catheter ablation of typical AFL involving the CTI has been confirmed to be a safe, effective, and 
well-established ablation procedure. Nevertheless, the CTI anatomy impacts ablation parameters, 
such as RF energy application. Moreover, difficult procedures are associated with longer CTI. 
Recesses can complicate ablation, and knowing where they might be present is useful to avoid them. 
Therefore, success rate and ablation complications can be optimized by a deep knowledge of anatomy 
and centre experience. 
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